Mapping	O
of	O
the	O
interaction	B-protein
site	I-protein
of	O
the	O
defective	B-protein
transcription	I-protein
factor	I-protein
in	O
the	O
class	B-cell_line
II	I-cell_line
major	I-cell_line
histocompatibility	I-cell_line
complex	I-cell_line
mutant	I-cell_line
cell	I-cell_line
line	I-cell_line
clone-13	I-cell_line
to	O
the	O
divergent	B-DNA
X2-box	I-DNA
.	O

We	O
have	O
previously	O
described	O
a	O
mutant	B-cell_line
B	I-cell_line
lymphoblastoid	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
Clone-13	B-cell_line
,	I-cell_line
that	O
expresses	O
HLA-DQ	B-protein
in	O
the	O
absence	O
of	O
HLA-DR	B-protein
and	I-protein
-DP	I-protein
.	O

Several	O
criteria	O
indicated	O
that	O
the	O
defect	O
in	O
this	O
cell	O
line	O
influences	O
the	O
activity	O
of	O
an	O
isotype-specific	B-protein
transcription	I-protein
factor	I-protein
.	O

Indeed	O
,	O
transient	O
transfection	O
of	O
HLA-DRA	B-DNA
and	I-DNA
DQB	I-DNA
reporter	I-DNA
constructs	I-DNA
indicated	O
that	O
the	O
affected	O
factor	O
operates	O
via	O
cis-elements	B-DNA
located	O
between	O
-141	B-DNA
base	I-DNA
pairs	I-DNA
and	O
the	O
transcription	B-DNA
initiation	I-DNA
site	I-DNA
.	O

A	O
series	O
of	O
hybrid	B-DNA
DRA/DQB	I-DNA
reporter	I-DNA
constructs	I-DNA
was	O
generated	O
to	O
further	O
map	O
the	O
relevant	O
cis-elements	B-DNA
in	O
this	O
system	O
.	O

Insertion	O
of	O
oligonucleotides	O
spanning	O
the	O
DQB	B-DNA
X-box	I-DNA
(	O
but	O
not	O
the	O
DQB-W	B-DNA
region	I-DNA
or	O
the	O
DQB	B-DNA
Y-box	I-DNA
)	O
upstream	B-DNA
of	I-DNA
-141	I-DNA
in	O
a	O
DRA	B-DNA
reporter	I-DNA
plasmid	I-DNA
rescued	O
expression	O
to	O
nearly	O
wild-type	O
levels	O
.	O

Substitution	O
promoters	O
were	O
then	O
generated	O
where	O
the	O
entire	O
X-box	B-DNA
,	O
or	O
only	O
the	O
X1-	B-DNA
or	I-DNA
X2-boxes	I-DNA
of	O
HLA-DRA	B-DNA
were	O
replaced	O
with	O
the	O
analogous	O
regions	O
of	O
HLA-DQB	B-DNA
.	O

The	O
DQB	B-DNA
X2-box	I-DNA
was	O
able	O
to	O
restore	O
expression	O
to	O
the	O
silent	B-DNA
DRA	I-DNA
reporter	I-DNA
construct	I-DNA
.	O

Moreover	O
,	O
replacement	O
of	O
the	O
DQB	B-DNA
X2-box	I-DNA
with	O
the	O
DRA	B-DNA
X2-box	I-DNA
markedly	O
diminished	O
the	O
activity	O
of	O
the	O
DQB	B-DNA
promoter	I-DNA
in	O
the	O
mutant	B-cell_line
cell	I-cell_line
.	O

None	O
of	O
the	O
hybrid	B-DNA
reporter	I-DNA
constructs	I-DNA
were	O
defective	O
when	O
transfected	O
into	O
the	O
wild-type	B-protein
,	O
HLA-DR/-DQ	B-cell_line
positive	I-cell_line
parental	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
Jijoye	B-cell_line
.	O

These	O
studies	O
suggest	O
that	O
the	O
divergent	B-DNA
X2-box	I-DNA
of	O
the	O
class	B-DNA
II	I-DNA
major	I-DNA
histocompatibility	I-DNA
complex	I-DNA
promoters	I-DNA
plays	O
an	O
important	O
role	O
in	O
influencing	O
differential	O
expression	O
of	O
the	O
human	B-DNA
class	I-DNA
II	I-DNA
isotypes	I-DNA
.	O

THE	NULL
JourNaL	NULL
or	NULL
BroLocICaL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

11	NULL
,	NULL
Issue	NULL
of	NULL
March	NULL
17	NULL
,	NULL
pp	NULL
.	NULL

6396-6402	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Mapping	NULL
of	NULL
the	NULL
Interaction	NULL
Site	NULL
of	NULL
the	NULL
Defective	NULL
Transcription	NULL
Factor	NULL
in	NULL
the	NULL
Class	NULL
II	NULL
Major	NULL
Histocompatibility	NULL
Complex	NULL
Mutant	NULL
Cell	NULL
Line	NULL
Clone-13	NULL
to	NULL
the	NULL
Divergent	NULL
X2-Box*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
13	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
December	NULL
19	NULL
,	NULL
1994	NULL
)	NULL
Santa	NULL
Jeremy	NULL
Ono	NULL
#	NULL
§	NULL
?	NULL

|**	NULL
and	NULL
Zhimin	NULL
Songt	NULL
From	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Medicine	NULL
and	NULL
the	NULL
Lucille	NULL
P.	NULL
Markey	NULL
Graduate	NULL
Program	NULL
in	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Medicine	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21224	NULL
,	NULL
the	NULL
§Department	NULL
of	NULL
Molecular	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Public	NULL
Health	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21205	NULL
,	NULL
and	NULL
the	NULL
[	NULL
Department	NULL
of	NULL
Biology	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21218	NULL
We	NULL
have	NULL
previously	NULL
described	NULL
a	NULL
mutant	NULL
B	NULL
lymphoblas-toid	NULL
cell	NULL
line	NULL
,	NULL
Clone-13	NULL
,	NULL
that	NULL
expresses	NULL
HLA-DQ	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
HLA-DR	NULL
and	NULL
-DP	NULL
.	NULL

Several	NULL
criteria	NULL
indicated	NULL
that	NULL
the	NULL
defect	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
influences	NULL
the	NULL
activity	NULL
of	NULL
an	NULL
isotype-specific	NULL
transcription	NULL
factor	NULL
.	NULL

Indeed	NULL
,	NULL
transient	NULL
transfection	NULL
of	NULL
HLA-DRA	NULL
and	NULL
DQB	NULL
reporter	NULL
constructs	NULL
indicated	NULL
that	NULL
the	NULL
affected	NULL
factor	NULL
operates	NULL
via	NULL
cis-elements	NULL
located	NULL
between	NULL
-141	NULL
base	NULL
pairs	NULL
and	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

A	NULL
series	NULL
of	NULL
hybrid	NULL
DRA/	NULL
DQB	NULL
reporter	NULL
constructs	NULL
was	NULL
generated	NULL
to	NULL
further	NULL
map	NULL
the	NULL
relevant	NULL
cis-elements	NULL
in	NULL
this	NULL
system	NULL
.	NULL

Insertion	NULL
of	NULL
oligonucleotides	NULL
spanning	NULL
the	NULL
DQB	NULL
X-box	NULL
(	NULL
but	NULL
not	NULL
the	NULL
DQB-W	NULL
region	NULL
or	NULL
the	NULL
DQB	NULL
Y-box	NULL
)	NULL
upstream	NULL
of	NULL
-141	NULL
in	NULL
a	NULL
DRA	NULL
reporter	NULL
plasmid	NULL
rescued	NULL
expression	NULL
to	NULL
nearly	NULL
wild-type	NULL
levels	NULL
.	NULL

Substitution	NULL
promoters	NULL
were	NULL
then	NULL
generated	NULL
where	NULL
the	NULL
entire	NULL
X-box	NULL
,	NULL
or	NULL
only	NULL
the	NULL
X1-	NULL
or	NULL
X2-boxes	NULL
of	NULL
HLA-DRA	NULL
were	NULL
replaced	NULL
with	NULL
the	NULL
analogous	NULL
regions	NULL
of	NULL
HLA-DQB	NULL
.	NULL

The	NULL
DQB	NULL
X2-box	NULL
was	NULL
able	NULL
to	NULL
restore	NULL
expression	NULL
to	NULL
the	NULL
silent	NULL
DRA	NULL
reporter	NULL
construct	NULL
.	NULL

Moreover	NULL
,	NULL
replacement	NULL
of	NULL
the	NULL
DQB	NULL
X2-box	NULL
with	NULL
the	NULL
DRA	NULL
X2-box	NULL
markedly	NULL
diminished	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
DQB	NULL
promoter	NULL
in	NULL
the	NULL
mutant	NULL
cell	NULL
.	NULL

None	NULL
of	NULL
the	NULL
hybrid	NULL
reporter	NULL
constructs	NULL
were	NULL
defective	NULL
when	NULL
transfected	NULL
into	NULL
the	NULL
wild-type	NULL
,	NULL
HLA-DR/-DQ	NULL
positive	NULL
parental	NULL
cell	NULL
line	NULL
,	NULL
Jijoye	NULL
.	NULL

These	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
divergent	NULL
X2-box	NULL
of	NULL
the	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
promoters	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
influencing	NULL
differential	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
class	NULL
II	NULL
isotypes	NULL
.	NULL

The	NULL
class	NULL
II	NULL
molecules	NULL
of	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
®	NULL
present	NULL
processed	NULL
peptides	NULL
derived	NULL
from	NULL
exoge-nous	NULL
antigen	NULL
to	NULL
CD4-positive	NULL
helper	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
human	NULL
genome	NULL
encodes	NULL
three	NULL
functional	NULL
isotypic	NULL
forms	NULL
of	NULL
these	NULL
molecules	NULL
(	NULL
HLA-DR	NULL
,	NULL
-DQ	NULL
,	NULL
and	NULL
-DP	NULL
)	NULL
,	NULL
each	NULL
of	NULL
which	NULL
is	NULL
a	NULL
disulfide-linked	NULL
heterodimer	NULL
of	NULL
two	NULL
transmembrane	NULL
glycoproteins	NULL
:	NULL
an	NULL
acidic	NULL
a	NULL
chain	NULL
and	NULL
a	NULL
B	NULL
chain	NULL
.	NULL

The	NULL
genes	NULL
encoding	NULL
these	NULL
polypeptides	NULL
are	NULL
clustered	NULL
in	NULL
discrete	NULL
loci	NULL
in	NULL
the	NULL
1	NULL
megabase	NULL
HLA-D	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
American	NULL
Diabetes	NULL
Association	NULL
,	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
,	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Hoffmann-LaRoche	NULL
,	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
and	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
(	NULL
to	NULL
S.	NULL
J	NULL
.	NULL

O	NULL
.	NULL
)	NULL

.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

**	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
5501	NULL
Hopkins	NULL
Bayview	NULL
Cir	NULL
.	NULL

,	NULL
Rm	NULL
.	NULL

24.38	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21224	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
410-550-2066	NULL
;	NULL
Fax	NULL
:	NULL
410-550-2090	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
MHC	NULL
,	NULL
major	NULL
histocompatibility	NULL
com-plex	NULL
;	NULL
BLS	NULL
,	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyl-transferase	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

region	NULL
on	NULL
the	NULL
short	NULL
arm	NULL
of	NULL
chromosome	NULL
6	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
related	NULL
class	NULL
I	NULL
MHC	NULL
molecules	NULL
,	NULL
which	NULL
bind	NULL
and	NULL
present	NULL
peptide	NULL
antigen	NULL
to	NULL
cytotoxic	NULL
T	NULL
cells	NULL
,	NULL
class	NULL
II	NULL
MHC	NULL
molecules	NULL
are	NULL
expressed	NULL
only	NULL
on	NULL
a	NULL
limited	NULL
number	NULL
of	NULL
cell	NULL
types	NULL
such	NULL
as	NULL
dendritic	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
on	NULL
these	NULL
cell	NULL
types	NULL
is	NULL
developmentally	NULL
regulated	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
molecules	NULL
can	NULL
also	NULL
be	NULL
induced	NULL
on	NULL
normally	NULL
class	NULL
II-negative	NULL
cells	NULL
by	NULL
specific	NULL
cytokines	NULL
such	NULL
as	NULL
interferon-y	NULL
or	NULL
interleukin-4	NULL
(	NULL
4	NULL
)	NULL
.	NULL

These	NULL
induction	NULL
pathways	NULL
are	NULL
probably	NULL
operating	NULL
at	NULL
sites	NULL
of	NULL
active	NULL
immune	NULL
response	NULL
,	NULL
where	NULL
de	NULL
novo	NULL
expression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
molecules	NULL
is	NULL
frequently	NULL
observed	NULL
.	NULL

De	NULL
novo	NULL
expression	NULL
of	NULL
class	NULL
I1	NULL
molecules	NULL
is	NULL
also	NULL
observed	NULL
at	NULL
target	NULL
sites	NULL
in	NULL
organ-specific	NULL
autoimmune	NULL
disease	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
hypothesized	NULL
that	NULL
this	NULL
might	NULL
trigger	NULL
or	NULL
exacerbate	NULL
the	NULL
disease	NULL
by	NULL
presentation	NULL
of	NULL
tissue-specific	NULL
antigen	NULL
to	NULL
helper	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
hereditary	NULL
MHC	NULL
class	NULL
II	NULL
deficiency	NULL
,	NULL
also	NULL
called	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
(	NULL
BLS	NULL
)	NULL
results	NULL
from	NULL
the	NULL
complete	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
MHC	NULL
molecules	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Patients	NULL
afflicted	NULL
with	NULL
this	NULL
autosomal	NULL
recessive	NULL
disease	NULL
are	NULL
prone	NULL
to	NULL
multiple	NULL
infections	NULL
and	NULL
usually	NULL
die	NULL
during	NULL
childhood	NULL
.	NULL

The	NULL
potential	NULL
association	NULL
of	NULL
these	NULL
two	NULL
types	NULL
of	NULL
disorders	NULL
with	NULL
aberrant	NULL
class	NULL
II	NULL
MHC	NULL
gene	NULL
expression	NULL
have	NULL
prompted	NULL
an	NULL
intense	NULL
analysis	NULL
of	NULL
the	NULL
regulatory	NULL
elements	NULL
and	NULL
transcription	NULL
factors	NULL
that	NULL
control	NULL
the	NULL
proper	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
is	NULL
mainly	NULL
transcrip-tional	NULL
,	NULL
and	NULL
all	NULL
of	NULL
the	NULL
class	NULL
II	NULL
proximal	NULL
promoters	NULL
studied	NULL
to	NULL
date	NULL
contain	NULL
highly	NULL
conserved	NULL
elements	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
X-	NULL
and	NULL
Y-boxes	NULL
(	NULL
3	NULL
)	NULL
.	NULL

A	NULL
number	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
these	NULL
and	NULL
other	NULL
less	NULL
conserved	NULL
sequences	NULL
have	NULL
been	NULL
iden-tified	NULL
,	NULL
and	NULL
complementary	NULL
DNAs	NULL
encoding	NULL
some	NULL
of	NULL
the	NULL
factors	NULL
have	NULL
been	NULL
molecularly	NULL
cloned	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
regulatory	NULL
roles	NULL
of	NULL
the	NULL
individual	NULL
recombinant	NULL
proteins	NULL
encoded	NULL
by	NULL
the	NULL
cDNAs	NULL
have	NULL
been	NULL
investigated	NULL
via	NULL
cotransfection	NULL
or	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
have	NULL
been	NULL
found	NULL
to	NULL
encode	NULL
both	NULL
activators	NULL
and	NULL
repressors	NULL
of	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
(	NULL
5-13	NULL
)	NULL
.	NULL

While	NULL
the	NULL
different	NULL
class	NULL
II	NULL
isotypes	NULL
HLA-DR	NULL
,	NULL
-DQ	NULL
,	NULL
and	NULL
-DP	NULL
are	NULL
usually	NULL
coordinately	NULL
expressed	NULL
,	NULL
there	NULL
is	NULL
now	NULL
abundant	NULL
evidence	NULL
that	NULL
differential	NULL
regulation	NULL
of	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
occurs	NULL
in	NULL
particular	NULL
cell	NULL
types	NULL
and	NULL
in	NULL
response	NULL
to	NULL
various	NULL
stimuli	NULL
(	NULL
4	NULL
,	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Such	NULL
differential	NULL
regulation	NULL
could	NULL
result	NULL
either	NULL
from	NULL
the	NULL
use	NULL
of	NULL
different	NULL
transcription	NULL
factors	NULL
or	NULL
from	NULL
mechanisms	NULL
that	NULL
would	NULL
selectively	NULL
inhibit	NULL
the	NULL
interaction	NULL
of	NULL
shared	NULL
transcription	NULL
factors	NULL
with	NULL
a	NULL
subset	NULL
of	NULL
the	NULL
class	NULL
II	NULL
gene	NULL
promoters	NULL
.	NULL

A	NULL
priori	NULL
,	NULL
both	NULL
mechanisms	NULL
appear	NULL
to	NULL
be	NULL
feasible	NULL
.	NULL

The	NULL
genes	NULL
encoding	NULL
the	NULL
a	NULL
and	NULL
B	NULL
chain	NULL
polypeptides	NULL
of	NULL
each	NULL
isotype	NULL
are	NULL
located	NULL
in	NULL
distinct	NULL
physically	NULL
separate	NULL
loci	NULL
(	NULL
approximately	NULL
350	NULL
kilobases	NULL
separate	NULL
the	NULL
DP	NULL
and	NULL
DQ	NULL
loci	NULL
and	NULL
approximately	NULL
100	NULL
kilobases	NULL
separate	NULL
the	NULL
DQ	NULL
and	NULL
DR	NULL
loci	NULL
)	NULL
,	NULL
which	NULL
could	NULL
easily	NULL
accommodate	NULL
distinct	NULL
chromatin	NULL
structures	NULL
at	NULL
each	NULL
locus	NULL
,	NULL
resulting	NULL
in	NULL
differ	NULL
6396	NULL
X2-Box	NULL
Control	NULL
of	NULL
Isotype	NULL
Specificity	NULL
of	NULL
MHC	NULL
Class	NULL
II	NULL
Genes	NULL
ential	NULL
accessibility	NULL
of	NULL
shared	NULL
transcription	NULL
factors	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
although	NULL
the	NULL
different	NULL
class	NULL
II	NULL
genes	NULL
share	NULL
highly	NULL
conserved	NULL
X-	NULL
and	NULL
Y-box	NULL
elements	NULL
,	NULL
the	NULL
nucleotide	NULL
sequence	NULL
of	NULL
intervening	NULL
and	NULL
surrounding	NULL
regions	NULL
of	NULL
the	NULL
proximal	NULL
promoter	NULL
diverge	NULL
significantly	NULL
.	NULL

Therefore	NULL
,	NULL
there	NULL
is	NULL
ample	NULL
opportunity	NULL
for	NULL
differential	NULL
binding	NULL
of	NULL
specific	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
various	NULL
class	NULL
II	NULL
promoters	NULL
.	NULL

Moreover	NULL
,	NULL
these	NULL
two	NULL
potential	NULL
control	NULL
mechanisms	NULL
for	NULL
differential	NULL
expression	NULL
are	NULL
not	NULL
necessarily	NULL
mutually	NULL
exclusive	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
described	NULL
a	NULL
mutant	NULL
cell	NULL
line	NULL
,	NULL
Clone-13	NULL
,	NULL
that	NULL
expresses	NULL
HLA-DQ	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
HLA-DR	NULL
and	NULL
-DP	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
variety	NULL
of	NULL
criteria	NULL
,	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
isotypes	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
was	NULL
shown	NULL
to	NULL
result	NULL
from	NULL
a	NULL
defect	NULL
in	NULL
(	NULL
or	NULL
operating	NULL
through	NULL
)	NULL
a	NULL
trans-acting	NULL
factor	NULL
since	NULL
the	NULL
transcriptionally	NULL
silent	NULL
genes	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
could	NULL
be	NULL
reactivated	NULL
upon	NULL
interspecific	NULL
fusion	NULL
with	NULL
a	NULL
MHC	NULL
class	NULL
II	NULL
positive	NULL
murine	NULL
cell	NULL
line	NULL
.	NULL

Transient	NULL
transfection	NULL
assays	NULL
also	NULL
indicated	NULL
that	NULL
the	NULL
defective	NULL
factor	NULL
operated	NULL
through	NULL
the	NULL
proximal	NULL
promoter	NULL
(	NULL
be-tween	NULL
-141	NULL
base	NULL
pairs	NULL
and	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
)	NULL
.	NULL

To	NULL
further	NULL
study	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
defective	NULL
transcription	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
the	NULL
human	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
we	NULL
have	NULL
more	NULL
precisely	NULL
mapped	NULL
the	NULL
cis-elements	NULL
that	NULL
mediate	NULL
this	NULL
defect	NULL
using	NULL
a	NULL
series	NULL
of	NULL
hybrid	NULL
promoter	NULL
constructs	NULL
between	NULL
the	NULL
transcriptionally	NULL
competent	NULL
HLA-DQB	NULL
gene	NULL
and	NULL
the	NULL
transcriptionally	NULL
silent	NULL
HLA-DRA	NULL
gene	NULL
.	NULL

The	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
divergent	NULL
X2-box	NULL
found	NULL
immediately	NULL
3	NULL
'	NULL
of	NULL
the	NULL
consensus	NULL
X1-box	NULL
mediates	NULL
the	NULL
isotype-specific	NULL
defect	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
and	NULL
provides	NULL
further	NULL
evidence	NULL
that	NULL
this	NULL
element	NULL
may	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
determining	NULL
the	NULL
isotype-specific	NULL
expression	NULL
observed	NULL
in	NULL
vivo	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Lines-Raji	NULL
(	NULL
ATCC	NULL
CCL86	NULL
)	NULL
,	NULL
RJ2.2.5	NULL
,	NULL
6.1.6	NULL
,	NULL
BLS-1	NULL
,	NULL
Clone-13	NULL
,	NULL
TF	NULL
,	NULL
Jurkat	NULL
,	NULL
JY	NULL
,	NULL
and	NULL
Jijoye	NULL
cells	NULL
were	NULL
all	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
5	NULL
x	NULL
103	NULL
units/100	NULL
ml	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
sodium	NULL
pyruvate	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
split	NULL
1:5	NULL
every	NULL
3	NULL
days	NULL
.	NULL

HeLa	NULL
cells	NULL
(	NULL
ATCC	NULL
CCL2	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
penicillin/streptomycin	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
as	NULL
RPMI	NULL
1640	NULL
complete	NULL
media	NULL
.	NULL

RJ2.2.5	NULL
is	NULL
derived	NULL
from	NULL
the	NULL
Burkitt	NULL
's	NULL
cell	NULL
line	NULL
Raji	NULL
(	NULL
DR2	NULL
,	NULL
DR10	NULL
)	NULL
after	NULL
irradiation	NULL
and	NULL
immunoselection	NULL
with	NULL
class	NULL
II-specific	NULL
monoclonal	NULL
antibodies	NULL
and	NULL
com-plement	NULL
.	NULL

Raji	NULL
cells	NULL
express	NULL
all	NULL
three	NULL
class	NULL
II	NULL
isotypes	NULL
,	NULL
while	NULL
RJ2.2.5	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
any	NULL
class	NULL
II	NULL
antigen	NULL
.	NULL

Jijoye	NULL
cells	NULL
(	NULL
also	NULL
originally	NULL
from	NULL
a	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
patient	NULL
)	NULL
were	NULL
originally	NULL
isolated	NULL
by	NULL
Pulvertaft	NULL
and	NULL
designated	NULL
then	NULL
as	NULL
P3	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Jijoye	NULL
cells	NULL
also	NULL
express	NULL
all	NULL
three	NULL
class	NULL
II	NULL
isotypes	NULL
.	NULL

Hinuma	NULL
et	NULL
al	NULL
.	NULL

(	NULL
18	NULL
)	NULL
then	NULL
isolated	NULL
subclones	NULL
of	NULL
the	NULL
line	NULL
in	NULL
semisolid	NULL
media	NULL
and	NULL
generated	NULL
a	NULL
line	NULL
designated	NULL
p3J-HR-1	NULL
,	NULL
which	NULL
is	NULL
a	NULL
high	NULL
producer	NULL
of	NULL
viral	NULL
capsid	NULL
antigen	NULL
.	NULL

Clone-13	NULL
cells	NULL
were	NULL
derived	NULL
by	NULL
further	NULL
subcloning	NULL
of	NULL
the	NULL
P3J	NULL
HR-1	NULL
cell	NULL
line	NULL
with	NULL
the	NULL
aim	NULL
of	NULL
producing	NULL
isogenic	NULL
cell	NULL
lines	NULL
with	NULL
varying	NULL
efficiencies	NULL
of	NULL
conversion	NULL
from	NULL
the	NULL
latent	NULL
to	NULL
lytic	NULL
cycles	NULL
of	NULL
the	NULL
virus	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
HLA	NULL
phenotype	NULL
of	NULL
the	NULL
Clone-13	NULL
cell	NULL
lines	NULL
is	NULL
class	NULL
I	NULL
positive	NULL
,	NULL
HLA-DQ	NULL
positive	NULL
(	NULL
DQ1	NULL
)	NULL
,	NULL
HLA-DR	NULL
,	NULL
and	NULL
-DP	NULL
negative	NULL
.	NULL

6.1.6	NULL
is	NULL
a	NULL
mutant	NULL
B-LCL	NULL
derived	NULL
from	NULL
the	NULL
T5.1	NULL
cell	NULL
line	NULL
that	NULL
does	NULL
not	NULL
express	NULL
any	NULL
of	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
20	NULL
)	NULL
.	NULL

BLS-1	NULL
and	NULL
TF	NULL
are	NULL
class	NULL
II-negative	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
patients	NULL
with	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
(	NULL
21	NULL
)	NULL
.	NULL

JY	NULL
is	NULL
a	NULL
class	NULL
II	NULL
positive	NULL
B-LCL	NULL
,	NULL
and	NULL
Jurkat	NULL
is	NULL
a	NULL
class	NULL
II-negative	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

Plasmid	NULL
Derivation	NULL
and	NULL
Construction-The	NULL
previously	NULL
described	NULL
plasmids	NULL
DQB160CAT	NULL
,	NULL
DRA	NULL
1028CAT	NULL
,	NULL
and	NULL
DRA300CAT	NULL
were	NULL
used	NULL
for	NULL
CAT	NULL
assay	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

The	NULL
DRA141CAT	NULL
(	NULL
construct	NULL
1	NULL
)	NULL
plasmid	NULL
was	NULL
generated	NULL
by	NULL
amplification	NULL
of	NULL
nucleotides	NULL
-141	NULL
to	NULL
+31	NULL
using	NULL
the	NULL
following	NULL
oligonucleotide	NULL
primers	NULL
:	NULL
5-GGGGAAGCTTTGTGTCCTGGACCCTTTGCAAGAA-3	NULL
'	NULL
and	NULL
5-GGGGTCTAGAAGCTCGGGAGTGAGGGAGAACAGACAA-3	NULL
'	NULL
.	NULL

The	NULL
template	NULL
for	NULL
the	NULL
amplification	NULL
was	NULL
plasmid	NULL
BSDRA300	NULL
containing	NULL
nucleotides	NULL
-260	NULL
to	NULL
+20	NULL
from	NULL
the	NULL
DRA	NULL
gene	NULL
inserted	NULL
between	NULL
the	NULL
HindIII	NULL
and	NULL
EcoRI	NULL
sites	NULL
of	NULL
the	NULL
pBlueserpt	NULL
cloning	NULL
vector	NULL
.	NULL
``	NULL

The	NULL
insert	NULL
for	NULL
this	NULL
plasmid	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
pp34-RI	NULL
fragment	NULL
originally	NULL
isolated	NULL
by	NULL
the	NULL
laboratory	NULL
of	NULL
S.	NULL
Weissman	NULL
,	NULL
Yale	NULL
University	NULL
(	NULL
22	NULL
)	NULL
.	NULL

These	NULL
primers	NULL
incorporate	NULL
unique	NULL
HindIII	NULL
and	NULL
Xbal	NULL
sites	NULL
into	NULL
the	NULL
amplification	NULL
product	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
then	NULL
purified	NULL
by	NULL
affinity	NULL
to	NULL
silica	NULL
fragments	NULL
(	NULL
Bio	NULL
101	NULL
)	NULL
,	NULL
°	NULL
S.	NULL
J.	NULL
Ono	NULL
,	NULL
unpublished	NULL
observations	NULL
.	NULL

6397	NULL
sequentially	NULL
digested	NULL
with	NULL
HindIII	NULL
and	NULL
Xbal	NULL
restriction	NULL
enzymes	NULL
,	NULL
subjected	NULL
to	NULL
a	NULL
second	NULL
round	NULL
of	NULL
purification	NULL
by	NULL
silica	NULL
affinity	NULL
,	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
pCAT	NULL
basic	NULL
plasmid	NULL
between	NULL
the	NULL
HindIII	NULL
and	NULL
Xbal	NULL
sites	NULL
(	NULL
Pro-mega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Construct	NULL
3	NULL
was	NULL
generated	NULL
by	NULL
amplification	NULL
of	NULL
the	NULL
DNA	NULL
fragment	NULL
containing	NULL
nucleotides	NULL
-173	NULL
to	NULL
~42	NULL
from	NULL
the	NULL
DQB	NULL
gene	NULL
promoter	NULL
using	NULL
purified	NULL
genomic	NULL
DNA	NULL
from	NULL
ATCC	NULL
CCL86	NULL
as	NULL
a	NULL
template	NULL
.	NULL

The	NULL
following	NULL
oligonucleotides	NULL
(	NULL
5'-GGGGAAGCTTAATTTGAA-GACGTCACAGTGC-3	NULL
'	NULL
and	NULL
5-GGGGAAGCTTTGGTAGGATTGGATG-GTCCTT-3	NULL
'	NULL
)	NULL
were	NULL
employed	NULL
and	NULL
introduce	NULL
HindIII	NULL
sites	NULL
on	NULL
both	NULL
ends	NULL
of	NULL
the	NULL
amplification	NULL
product	NULL
.	NULL

After	NULL
purification	NULL
and	NULL
restriction	NULL
with	NULL
HindIII	NULL
,	NULL
this	NULL
DQB	NULL
proximal	NULL
promoter	NULL
fragment	NULL
(	NULL
lacking	NULL
its	NULL
own	NULL
transcription	NULL
initiation	NULL
site	NULL
)	NULL
was	NULL
inserted	NULL
into	NULL
HindIII	NULL
cleaved/calf	NULL
intestinal	NULL
alkaline	NULL
phosphatase-treated	NULL
construct	NULL
1	NULL
.	NULL

Constructs	NULL
4-6	NULL
were	NULL
generated	NULL
by	NULL
first	NULL
producing	NULL
double-stranded	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
following	NULL
strands	NULL
and	NULL
their	NULL
complements	NULL
by	NULL
annealing	NULL
via	NULL
sequential	NULL
incubation	NULL
in	NULL
decreasing	NULL
temperatures	NULL
:	NULL
DQB	NULL
W	NULL
,	NULL
5-TCCAGTGCAGGCACTGGATTCA-GAACCTTCACAAAAAAAAAA-3	NULL
'	NULL
;	NULL
DQB	NULL
X	NULL
,	NULL
5-CAAAAAAAAAATCTGC-CCAGAGACAGATGAGGTCCTTCAG-3	NULL
'	NULL
;	NULL
DQB	NULL
Y	NULL
,	NULL
5-GTCCTTCAGCTC-CAGTGCTGATTGGTTCCTTTCCAAGG-3	NULL
'	NULL
.	NULL

These	NULL
blunt	NULL
ended	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
then	NULL
li-gated	NULL
,	NULL
and	NULL
dimers	NULL
were	NULL
purified	NULL
by	NULL
elution	NULL
from	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

HindIII	NULL
linkers	NULL
were	NULL
then	NULL
attached	NULL
to	NULL
the	NULL
purifed	NULL
dimers	NULL
,	NULL
the	NULL
ligation	NULL
products	NULL
were	NULL
cleaved	NULL
with	NULL
HindIII	NULL
,	NULL
and	NULL
the	NULL
purified	NULL
dimers	NULL
were	NULL
ligated	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
construct	NULL
1	NULL
.	NULL

The	NULL
orientation	NULL
and	NULL
number	NULL
of	NULL
oligonucleotides	NULL
inserted	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
DRA	NULL
primer	NULL
(	NULL
5'-TCTTGCAAAGGGTCCAGGACA-3	NULL
'	NULL
)	NULL
,	NULL
which	NULL
primes	NULL
synthesis	NULL
of	NULL
the	NULL
``	NULL
bottom	NULL
``	NULL
strand	NULL
of	NULL
the	NULL
DRA	NULL
proximal	NULL
promoter	NULL
oriented	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
toward	NULL
the	NULL
upstream	NULL
direction	NULL
.	NULL

Constructs	NULL
containing	NULL
two	NULL
oligonucleotides	NULL
ligated	NULL
in	NULL
the	NULL
wild-type	NULL
orientation	NULL
were	NULL
identified	NULL
and	NULL
propagated	NULL
.	NULL

Construct	NULL
7	NULL
was	NULL
generated	NULL
by	NULL
first	NULL
ligating	NULL
the	NULL
564-base	NULL
pair	NULL
HindIII	NULL
fragment	NULL
of	NULL
bacteriophage	NULL
A	NULL
DNA	NULL
to	NULL
the	NULL
DQBX-box	NULL
dimer	NULL
isolated	NULL
from	NULL
construct	NULL
5	NULL
,	NULL
followed	NULL
by	NULL
gel	NULL
purification	NULL
of	NULL
the	NULL
dimer/564-base	NULL
pair	NULL
ligation	NULL
products	NULL
.	NULL

This	NULL
was	NULL
then	NULL
ligated	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
construct	NULL
1	NULL
.	NULL

Plasmids	NULL
containing	NULL
the	NULL
DQBX-box	NULL
dimer	NULL
ligated	NULL
in	NULL
the	NULL
wild-type	NULL
orientation	NULL
were	NULL
identified	NULL
by	NULL
dideoxy	NULL
sequence	NULL
analysis	NULL
using	NULL
a	NULL
primer	NULL
that	NULL
initiates	NULL
DNA	NULL
synthesis	NULL
through	NULL
the	NULL
HindIII	NULL
insertion	NULL
site	NULL
from	NULL
the	NULL
plasmid	NULL
backbone	NULL
.	NULL

Construct	NULL
8	NULL
was	NULL
generated	NULL
by	NULL
first	NULL
ligating	NULL
the	NULL
2,822-base	NULL
pair	NULL
bacteriophage	NULL
A	NULL
HindIII	NULL
fragment	NULL
to	NULL
the	NULL
DQBX-box	NULL
dimer	NULL
,	NULL
followed	NULL
by	NULL
gel	NULL
purification	NULL
of	NULL
the	NULL
dimer/2,822	NULL
ligation	NULL
products	NULL
.	NULL

This	NULL
was	NULL
then	NULL
inserted	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
construct	NULL
1	NULL
.	NULL

Construct	NULL
9	NULL
was	NULL
generated	NULL
by	NULL
ligating	NULL
BamH	NULL
]	NULL
linkers	NULL
onto	NULL
the	NULL
DQBX-box	NULL
dimer	NULL
,	NULL
cleaving	NULL
with	NULL
BamHI	NULL
,	NULL
and	NULL
insertion	NULL
of	NULL
the	NULL
dimer	NULL
into	NULL
the	NULL
unique	NULL
BamHI	NULL
site	NULL
downstream	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
in	NULL
the	NULL
pCAT	NULL
basic	NULL
plasmid	NULL
.	NULL

Constructs	NULL
10-14	NULL
were	NULL
generated	NULL
by	NULL
overlap	NULL
PCR	NULL
of	NULL
two	NULL
or	NULL
three	NULL
PCR	NULL
subfragments	NULL
to	NULL
generate	NULL
the	NULL
final	NULL
chimeric	NULL
class	NULL
II	NULL
promoters	NULL
.	NULL

The	NULL
nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
recombination	NULL
sites	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
appropriate	NULL
figures	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
(	NULL
23	NULL
)	NULL
and	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-500	NULL
ml	NULL
of	NULL
log	NULL
phase	NULL
cells	NULL
was	NULL
pelleted	NULL
at	NULL
2,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
cell	NULL
pellet	NULL
was	NULL
washed	NULL
twice	NULL
in	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
resuspended	NULL
in	NULL
25	NULL
ml	NULL
of	NULL
nuclear	NULL
isolation	NULL
buffer	NULL
I	NULL
(	NULL
10	NULL
mm	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
dithio-threitol	NULL
)	NULL
.	NULL

0.3	NULL
ml	NULL
of	NULL
ice-cold	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
dropwise	NULL
(	NULL
while	NULL
vortexing	NULL
at	NULL
lowest	NULL
setting	NULL
)	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
cell	NULL
lysate	NULL
was	NULL
layered	NULL
onto	NULL
12	NULL
ml	NULL
of	NULL
ice-cold	NULL
nuclear	NULL
isolation	NULL
buffer	NULL
I	NULL
containing	NULL
1.7	NULL
M	NULL
sucrose	NULL
and	NULL
centrifuged	NULL
at	NULL
13,000	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
in	NULL
an	NULL
SW27	NULL
rotor	NULL
(	NULL
Beckman	NULL
Instruments	NULL
,	NULL
Inc.	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Purified	NULL
nuclei	NULL
were	NULL
then	NULL
resuspended	NULL
in	NULL
3	NULL
ml	NULL
of	NULL
ice-cold	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.42	NULL
M	NULL
NaCl	NULL
,	NULL
1.5	NULL
mm	NULL
MgC12	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mm	NULL
phenyl-methylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
homogenized	NULL
with	NULL
10	NULL
strokes	NULL
of	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
then	NULL
rocked	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
and	NULL
centrifuged	NULL
for	NULL
30	NULL
min	NULL
at	NULL
25,000	NULL
x	NULL
g	NULL
in	NULL
an	NULL
$	NULL
$	NULL
34	NULL
rotor	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
then	NULL
dialyzed	NULL
against	NULL
150	NULL
ml	NULL
of	NULL
transcription	NULL
buffer	NULL
(	NULL
-rNTPs	NULL
)	NULL
(	NULL
12	NULL
mm	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
12	NULL
%	NULL
glycerol	NULL
,	NULL
0.3	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
0.12	NULL
mm	NULL
EDTA	NULL
,	NULL
and	NULL
60	NULL
mm	NULL
KCl	NULL
for	NULL
5	NULL
h	NULL
)	NULL
.	NULL

MgCl	NULL
,	NULL
was	NULL
omitted	NULL
from	NULL
these	NULL
preparations	NULL
as	NULL
it	NULL
inhibits	NULL
some	NULL
of	NULL
the	NULL
complexes	NULL
discussed	NULL
in	NULL
this	NULL
report	NULL
.	NULL

For	NULL
EMSA	NULL
,	NULL
a	NULL
double-stranded	NULL
probe	NULL
spanning	NULL
nucleotides	NULL
-141	NULL
to	NULL
-43	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
,	NULL
labeled	NULL
by	NULL
polynucle-otide	NULL
kinase	NULL
,	NULL
and	NULL
separated	NULL
from	NULL
unincorporated	NULL
°°P	NULL
by	NULL
spun-column	NULL
chromatography	NULL
on	NULL
Biogel	NULL
P-2	NULL
.	NULL

DNA	NULL
binding	NULL
was	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
10	NULL
pl	NULL
volume	NULL
containing	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
and	NULL
5,000	NULL
cpm	NULL
of	NULL
radiolabeled	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
50	NULL
mm	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

The	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
then	NULL
resolved	NULL
from	NULL
free	NULL
DNA	NULL
by	NULL
separation	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
products	NULL
were	NULL
then	NULL
visualized	NULL
by	NULL
autora-diography	NULL
of	NULL
the	NULL
fixed	NULL
,	NULL
dried	NULL
gel	NULL
.	NULL

Transfections	NULL
and	NULL
CAT	NULL
Assays-10	NULL
``	NULL
recipient	NULL
cells	NULL
were	NULL
washed	NULL
ex	NULL
6398	NULL
tensively	NULL
with	NULL
serum-free	NULL
media	NULL
.	NULL

20	NULL
ug	NULL
of	NULL
cesium	NULL
chloride-purified	NULL
supercoiled	NULL
plasmid	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
in	NULL
a	NULL
1-ml	NULL
volume	NULL
of	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
containing	NULL
either	NULL
20	NULL
wl	NULL
of	NULL
lipofectamine	NULL
or	NULL
200	NULL
ug	NULL
of	NULL
DEAE-dextran	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
and	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
plasmid	NULL
pXGHS5	NULL
,	NULL
a	NULL
mammalian	NULL
expression	NULL
vector	NULL
encoding	NULL
human	NULL
growth	NULL
hormone	NULL
,	NULL
was	NULL
cotransfected	NULL
with	NULL
reporter	NULL
constructs	NULL
to	NULL
control	NULL
for	NULL
variability	NULL
in	NULL
transfection	NULL
efficiency	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
lipofectamine	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
50	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
.	NULL

For	NULL
DEAE-dextran	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
medium	NULL
.	NULL

48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
serum-free	NULL
media	NULL
and	NULL
pelleted	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
300	NULL
pl	NULL
of	NULL
0.25	NULL
m	NULL
Tris	NULL
and	NULL
freeze-thawed	NULL
3	NULL
times	NULL
.	NULL

After	NULL
centrifugation	NULL
to	NULL
remove	NULL
debris	NULL
,	NULL
150	NULL
ul	NULL
of	NULL
the	NULL
cell	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
20	NULL
ul	NULL
of	NULL
10	NULL
mM	NULL
acetyl-coenzyme	NULL
A	NULL
(	NULL
Pharmacia	NULL
)	NULL
and	NULL
2	NULL
wl	NULL
of	NULL
chloramphenicol	NULL
(	NULL
DuPont	NULL
NEN	NULL
)	NULL
(	NULL
49	NULL
mCi/	NULL
mmol	NULL
,	NULL
0.1	NULL
mCi/ml	NULL
)	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
chloramphenicol	NULL
was	NULL
then	NULL
extracted	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
ethyl	NULL
acetate	NULL
,	NULL
speed	NULL
vacuum	NULL
dried	NULL
,	NULL
and	NULL
spotted	NULL
onto	NULL
thin-layer	NULL
chromatography	NULL
plates	NULL
.	NULL

After	NULL
the	NULL
solvent	NULL
front	NULL
was	NULL
allowed	NULL
to	NULL
travel	NULL
three-quarters	NULL
of	NULL
the	NULL
length	NULL
of	NULL
the	NULL
plate	NULL
,	NULL
the	NULL
plate	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
chromatography	NULL
tank	NULL
,	NULL
allowed	NULL
to	NULL
dry	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
DQB	NULL
Upstream	NULL
cis-Elements	NULL
Located	NULL
Between	NULL
Positions	NULL
-173	NULL
and	NULL
-42	NULL
Inserted	NULL
Upstream	NULL
of	NULL
Nucleotide	NULL
=-141	NULL
in	NULL
a	NULL
DRACAT	NULL
Reporter	NULL
Plasmid	NULL
Restores	NULL
Expression	NULL
in	NULL
Clone-13	NULL
Cells-The	NULL
finding	NULL
that	NULL
the	NULL
HLA-DQB	NULL
promoter	NULL
is	NULL
active	NULL
and	NULL
that	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
is	NULL
inactive	NULL
(	NULL
directing	NULL
a	NULL
transcriptional	NULL
activity	NULL
6	NULL
%	NULL
of	NULL
the	NULL
DQB	NULL
promoter	NULL
activity	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
in	NULL
Clone-13	NULL
cells	NULL
indicated	NULL
an	NULL
approach	NULL
to	NULL
further	NULL
dissect	NULL
the	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
differential	NULL
expression	NULL
of	NULL
these	NULL
two	NULL
human	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
.	NULL

This	NULL
approach	NULL
was	NULL
to	NULL
generate	NULL
chimeric	NULL
reporter	NULL
constructs	NULL
using	NULL
portions	NULL
of	NULL
the	NULL
two	NULL
promoters	NULL
and	NULL
to	NULL
assess	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
chimeric	NULL
constructs	NULL
to	NULL
support	NULL
transcription	NULL
of	NULL
the	NULL
bacterial	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
upon	NULL
transient	NULL
transfection	NULL
into	NULL
this	NULL
cell	NULL
line	NULL
.	NULL

To	NULL
test	NULL
the	NULL
feasibility	NULL
of	NULL
this	NULL
approach	NULL
,	NULL
an	NULL
initial	NULL
construct	NULL
was	NULL
generated	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
construct	NULL
3	NULL
)	NULL
,	NULL
where	NULL
nucleotides	NULL
-173	NULL
to	NULL
-42	NULL
from	NULL
the	NULL
DQB	NULL
promoter	NULL
were	NULL
ligated	NULL
upstream	NULL
of	NULL
nucleotide	NULL
-141	NULL
in	NULL
a	NULL
DRA	NULL
reporter	NULL
plasmid	NULL
,	NULL
in	NULL
the	NULL
correct	NULL
orientation	NULL
.	NULL

These	NULL
nucleotides	NULL
from	NULL
the	NULL
DQB	NULL
promoter	NULL
were	NULL
chosen	NULL
since	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
only	NULL
these	NULL
nucleotides	NULL
ligated	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
was	NULL
transcriptionally	NULL
inactive	NULL
(	NULL
having	NULL
only	NULL
3	NULL
%	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
DQB	NULL
reporter	NULL
constructs	NULL
containing	NULL
downstream	NULL
nucleotides	NULL
up	NULL
to	NULL
+30	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
while	NULL
retaining	NULL
all	NULL
of	NULL
the	NULL
important	NULL
conserved	NULL
upstream	NULL
activation	NULL
sequences	NULL
.	NULL

The	NULL
insertion	NULL
of	NULL
these	NULL
nucleotides	NULL
from	NULL
DQB	NULL
upstream	NULL
of	NULL
the	NULL
-141	NULL
DRA	NULL
reporter	NULL
plasmid	NULL
conferred	NULL
a	NULL
transcriptional	NULL
activity	NULL
approximately	NULL
80	NULL
%	NULL
of	NULL
that	NULL
conferred	NULL
by	NULL
the	NULL
wild-type	NULL
DQB160CAT	NULL
reporter	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicated	NULL
that	NULL
the	NULL
generation	NULL
of	NULL
further	NULL
hybrid	NULL
reporter	NULL
constructs	NULL
was	NULL
a	NULL
feasible	NULL
approach	NULL
to	NULL
map	NULL
divergent	NULL
cis-elements	NULL
within	NULL
these	NULL
two	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

Insertion	NULL
of	NULL
Dimerized	NULL
HLA-DQB	NULL
X-Box	NULL
Oligonucleotides	NULL
Upstream	NULL
of	NULL
Nucleotide	NULL
-141	NULL
of	NULL
the	NULL
HLA-DRA	NULL
Promoter	NULL
Restores	NULL
Expression	NULL
in	NULL
the	NULL
Mutant	NULL
Cell	NULL
Line	NULL
,	NULL
Clone-13-As	NULL
a	NULL
first	NULL
step	NULL
in	NULL
mapping	NULL
regions	NULL
of	NULL
the	NULL
HLA-DRA	NULL
and	NULL
-DQB	NULL
promoters	NULL
that	NULL
might	NULL
mediate	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
genes	NULL
in	NULL
the	NULL
Clone-13	NULL
cell	NULL
line	NULL
,	NULL
an	NULL
initial	NULL
series	NULL
of	NULL
six	NULL
chimeric	NULL
reporter	NULL
plasmids	NULL
was	NULL
constructed	NULL
to	NULL
rapidly	NULL
screen	NULL
for	NULL
general	NULL
subregions	NULL
of	NULL
the	NULL
promoters	NULL
that	NULL
might	NULL
mediate	NULL
differential	NULL
expression	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
the	NULL
conserved	NULL
W	NULL
(	NULL
S	NULL
)	NULL
,	NULL
X-and	NULL
Y-boxes	NULL
and	NULL
surrounding	NULL
nucleotides	NULL
from	NULL
the	NULL
DQB	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
were	NULL
concatenated	NULL
and	NULL
subcloned	NULL
upstream	NULL
of	NULL
nucleotide	NULL
-141	NULL
in	NULL
the	NULL
DRACAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
plasmids	NULL
containing	NULL
dimers	NULL
of	NULL
the	NULL
oligonucleotides	NULL
arranged	NULL
in	NULL
``	NULL
head	NULL
to	NULL
tail	NULL
``	NULL
orientations	NULL
were	NULL
selected	NULL
and	NULL
expanded	NULL
.	NULL

While	NULL
the	NULL
hybrid	NULL
reporter	NULL
constructs	NULL
containing	NULL
dimers	NULL
of	NULL
the	NULL
DQB	NULL
W	NULL
(	NULL
S	NULL
)	NULL
region	NULL
(	NULL
construct	NULL
4	NULL
)	NULL
and	NULL
the	NULL
DQB	NULL
Y-box	NULL
region	NULL
(	NULL
construct	NULL
X2-Box	NULL
Control	NULL
of	NULL
Isotype	NULL
Specificity	NULL
of	NULL
MHC	NULL
Class	NULL
II	NULL
Genes	NULL
A	NULL
1	NULL
cenas	NULL
4	NULL
-	NULL
m	NULL
fe	NULL
5	NULL
ooo	NULL
~~~	NULL
~	NULL
--	NULL
»	NULL
-+	NULL
DRA	NULL
(	NULL
-141	NULL
to	NULL
+31	NULL
)	NULL
poem	NULL
CAT	NULL
DQB	NULL
w	NULL
TccactocacccAc	NULL
-~	NULL
Cont	NULL
DQB	NULL
X	NULL
DQB	NULL
Y	NULL
GTCCTTCAGCT	NULL
GZA	NULL
120	NULL
100	NULL
80	NULL
60	NULL
40	NULL
Relative	NULL
CAT	NULL
Activity	NULL
20	NULL
Construct	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Insertion	NULL
of	NULL
two	NULL
DQB	NULL
X-box	NULL
oligonucleotides	NULL
upstream	NULL
of	NULL
-141	NULL
in	NULL
a	NULL
DRACAT	NULL
reporter	NULL
plasmid	NULL
restores	NULL
expression	NULL
in	NULL
Clone-13	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
scheme	NULL
for	NULL
construction	NULL
of	NULL
hybrid	NULL
constructs	NULL
from	NULL
a	NULL
173	NULL
to	NULL
-42	NULL
DQB	NULL
amplification	NULL
product	NULL
and	NULL
dimerized	NULL
DQB	NULL
W	NULL
(	NULL
S	NULL
)	NULL
,	NULL
X-and	NULL
Y-box	NULL
oligonucleotides	NULL
.	NULL

As	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
,	NULL
``	NULL
the	NULL
PCR	NULL
product	NULL
and	NULL
oligonucleotides	NULL
were	NULL
inserted	NULL
upstream	NULL
of	NULL
nucleotide	NULL
-141	NULL
in	NULL
the	NULL
DRA141CAT	NULL
reporter	NULL
plasmid	NULL
.	NULL

The	NULL
numbers	NULL
refer	NULL
to	NULL
the	NULL
construct	NULL
designations	NULL
referred	NULL
to	NULL
in	NULL
the	NULL
text	NULL
,	NULL
and	NULL
the	NULL
oligonucleotide	NULL
sequences	NULL
are	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
this	NULL
panel	NULL
.	NULL

The	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
conserved	NULL
elements	NULL
are	NULL
boxed	NULL
in	NULL
solid	NULL
black	NULL
boxes	NULL
over	NULL
the	NULL
sequences	NULL
.	NULL

A	NULL
representative	NULL
CAT	NULL
assay	NULL
from	NULL
transfection	NULL
of	NULL
Clone-13	NULL
cells	NULL
with	NULL
these	NULL
constructs	NULL
is	NULL
shown	NULL
.	NULL

B	NULL
,	NULL
results	NULL
of	NULL
quantitation	NULL
of	NULL
transfections	NULL
of	NULL
the	NULL
constructs	NULL
in	NULL
1A	NULL
into	NULL
Clone-13	NULL
cells	NULL
using	NULL
three	NULL
independent	NULL
plasmid	NULL
preparations	NULL
and	NULL
and	NULL
an	NULL
n	NULL
5	NULL
for	NULL
each	NULL
plasmid	NULL
preparation	NULL
.	NULL

The	NULL
results	NULL
are	NULL
relative	NULL
CAT	NULL
activities	NULL
using	NULL
the	NULL
mean	NULL
DQBCAT	NULL
activity	NULL
as	NULL
a	NULL
100	NULL
%	NULL
maximum	NULL
activity	NULL
.	NULL

The	NULL
p	NULL
values	NULL
for	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
are	NULL
<	NULL
0.005	NULL
relative	NULL
to	NULL
1	NULL
,	NULL
and	NULL
p	NULL
<	NULL
0.05	NULL
for	NULL
7	NULL
relative	NULL
to	NULL
1	NULL
6	NULL
)	NULL
did	NULL
not	NULL
have	NULL
transcriptional	NULL
activities	NULL
significantly	NULL
different	NULL
from	NULL
the	NULL
wild-type	NULL
DRA	NULL
reporter	NULL
plasmid	NULL
(	NULL
construct	NULL
1	NULL
)	NULL
,	NULL
the	NULL
plasmid	NULL
containing	NULL
dimers	NULL
of	NULL
the	NULL
DQBX-box	NULL
region	NULL
had	NULL
a	NULL
transcriptional	NULL
activity	NULL
that	NULL
was	NULL
elevated	NULL
10-fold	NULL
over	NULL
the	NULL
wild-type	NULL
DRA	NULL
reporter	NULL
plasmid	NULL
and	NULL
which	NULL
was	NULL
50	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
DQB	NULL
reporter	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicated	NULL
that	NULL
an	NULL
element	NULL
or	NULL
elements	NULL
within	NULL
the	NULL
X-box	NULL
region	NULL
of	NULL
these	NULL
class	NULL
II	NULL
genes	NULL
mediate	NULL
differential	NULL
expression	NULL
of	NULL
the	NULL
genes	NULL
.	NULL

X2-Box	NULL
Control	NULL
of	NULL
Isotype	NULL
Specificity	NULL
of	NULL
MHC	NULL
Class	NULL
II	NULL
Genes	NULL
Insertion	NULL
of	NULL
Appreciable	NULL
Distance	NULL
between	NULL
the	NULL
DQB	NULL
X-Box	NULL
Oligonucleotides	NULL
and	NULL
the	NULL
DRA	NULL
Transcription	NULL
Initiation	NULL
Site	NULL
Interferes	NULL
with	NULL
the	NULL
Ability	NULL
of	NULL
the	NULL
DQB	NULL
X-Box	NULL
Elements	NULL
to	NULL
Restore	NULL
Expression	NULL
to	NULL
the	NULL
DRA	NULL
Promoter-Constructs	NULL
4-6	NULL
contain	NULL
dimers	NULL
of	NULL
DQB	NULL
upstream	NULL
elements	NULL
ligated	NULL
upstream	NULL
of	NULL
nucleotide	NULL
-141	NULL
in	NULL
the	NULL
DRA	NULL
promoter	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
X-box	NULL
oligonucleotides	NULL
,	NULL
this	NULL
places	NULL
the	NULL
inserted	NULL
elements	NULL
49	NULL
bases	NULL
upstream	NULL
of	NULL
their	NULL
natural	NULL
position	NULL
within	NULL
the	NULL
promoter	NULL
,	NULL
approximately	NULL
five	NULL
complete	NULL
helical	NULL
turns	NULL
from	NULL
the	NULL
DRA	NULL
X-box	NULL
.	NULL

Assuming	NULL
that	NULL
the	NULL
restoration	NULL
of	NULL
expression	NULL
by	NULL
the	NULL
upstream	NULL
DQB	NULL
X-box	NULL
dimers	NULL
results	NULL
from	NULL
protein-protein	NULL
interactions	NULL
between	NULL
transcription	NULL
factors	NULL
bound	NULL
to	NULL
the	NULL
inserted	NULL
elements	NULL
and	NULL
DQB	NULL
promoter	NULL
binding	NULL
proteins	NULL
(	NULL
or	NULL
general	NULL
transcriptional	NULL
machinery	NULL
)	NULL
,	NULL
three	NULL
additional	NULL
constructs	NULL
were	NULL
synthesized	NULL
inserting	NULL
additional	NULL
distance	NULL
between	NULL
the	NULL
DQB	NULL
X-box	NULL
dimers	NULL
and	NULL
the	NULL
DRA	NULL
X-box	NULL
element	NULL
to	NULL
determine	NULL
the	NULL
distance	NULL
and	NULL
helical-orientation	NULL
requirements	NULL
for	NULL
these	NULL
interactions	NULL
.	NULL

Construct	NULL
7	NULL
introduces	NULL
an	NULL
additional	NULL
56.4	NULL
helical	NULL
turns	NULL
between	NULL
the	NULL
inserted	NULL
and	NULL
DRA	NULL
X-boxes	NULL
;	NULL
construct	NULL
8	NULL
introduces	NULL
an	NULL
additional	NULL
232.2	NULL
helical	NULL
turns	NULL
;	NULL
and	NULL
construct	NULL
9	NULL
places	NULL
the	NULL
dimer	NULL
175.2	NULL
helical	NULL
turns	NULL
downstream	NULL
of	NULL
the	NULL
DRA	NULL
X-box	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Of	NULL
these	NULL
constructs	NULL
,	NULL
only	NULL
construct	NULL
7	NULL
exhibited	NULL
a	NULL
transcriptional	NULL
activity	NULL
that	NULL
was	NULL
significantly	NULL
above	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
DRA	NULL
reporter	NULL
(	NULL
a	NULL
4-fold	NULL
elevation	NULL
and	NULL
a	NULL
P-value	NULL
<	NULL
0.05	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
DQB	NULL
X-box	NULL
dimer	NULL
is	NULL
located	NULL
on	NULL
the	NULL
opposite	NULL
side	NULL
of	NULL
the	NULL
helix	NULL
relative	NULL
to	NULL
the	NULL
DRA	NULL
X-box	NULL
,	NULL
this	NULL
indicates	NULL
that	NULL
the	NULL
additional	NULL
inserted	NULL
distance	NULL
may	NULL
allow	NULL
flexibility	NULL
to	NULL
the	NULL
usual	NULL
requirement	NULL
for	NULL
strict	NULL
stereo-specificity	NULL
of	NULL
the	NULL
X-	NULL
and	NULL
Y-box	NULL
elements	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
inactivity	NULL
of	NULL
plasmids	NULL
8	NULL
and	NULL
9	NULL
(	NULL
which	NULL
are	NULL
stereospecifically	NULL
aligned	NULL
with	NULL
the	NULL
DRA	NULL
Y-box	NULL
)	NULL
,	NULL
however	NULL
,	NULL
indicates	NULL
that	NULL
the	NULL
additional	NULL
distances	NULL
between	NULL
the	NULL
DQB	NULL
X-box	NULL
dimer	NULL
and	NULL
the	NULL
DRA	NULL
Y-box	NULL
are	NULL
excessively	NULL
large	NULL
to	NULL
allow	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Replacement	NULL
of	NULL
the	NULL
X1	NULL
and	NULL
X2	NULL
Elements	NULL
in	NULL
the	NULL
HLA-DRA	NULL
Promoter	NULL
with	NULL
the	NULL
Analogous	NULL
DQB	NULL
Elements	NULL
Maps	NULL
DRA	NULL
Complementation	NULL
Activity	NULL
to	NULL
the	NULL
DQB	NULL
X2-Box-Since	NULL
the	NULL
previous	NULL
experiments	NULL
indicated	NULL
that	NULL
the	NULL
extended	NULL
X-box	NULL
element	NULL
and	NULL
surrounding	NULL
nucleotides	NULL
might	NULL
mediate	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
the	NULL
DRA	NULL
and	NULL
DQB	NULL
genes	NULL
in	NULL
Clone-13	NULL
,	NULL
additional	NULL
constructs	NULL
were	NULL
synthesized	NULL
by	NULL
overlap	NULL
PCR	NULL
to	NULL
1	NULL
)	NULL
more	NULL
precisely	NULL
map	NULL
the	NULL
relevant	NULL
element	NULL
and	NULL
2	NULL
)	NULL
to	NULL
address	NULL
the	NULL
question	NULL
using	NULL
substitution	NULL
constructs	NULL
where	NULL
the	NULL
inserted	NULL
element	NULL
replaces	NULL
the	NULL
wild-type	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Construct	NULL
10	NULL
replaces	NULL
the	NULL
nucleotide	NULL
sequence	NULL
5	NULL
(	NULL
-CCTAGCAACAGATGCGTCATC-TC-3	NULL
'	NULL
containing	NULL
the	NULL
DRA	NULL
X1-	NULL
and	NULL
X2-boxes	NULL
(	NULL
and	NULL
not	NULL
the	NULL
py-rimidine	NULL
tract	NULL
found	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
X1-box	NULL
,	NULL
or	NULL
the	NULL
A/T-rich	NULL
HMG	NULL
I/Y	NULL
binding	NULL
site	NULL
located	NULL
in	NULL
the	NULL
interspace	NULL
region	NULL
)	NULL
with	NULL
the	NULL
sequence	NULL
5'-CCCAGAGACAGATGAGGTC-CTTC-3	NULL
'	NULL
containing	NULL
both	NULL
the	NULL
X1-	NULL
and	NULL
X2-boxes	NULL
from	NULL
DQB	NULL
.	NULL

This	NULL
replacement	NULL
and	NULL
the	NULL
others	NULL
described	NULL
later	NULL
in	NULL
this	NULL
work	NULL
were	NULL
designed	NULL
so	NULL
that	NULL
no	NULL
alterations	NULL
in	NULL
the	NULL
helical	NULL
orientation	NULL
or	NULL
distance	NULL
of	NULL
the	NULL
new	NULL
element	NULL
(	NULL
relative	NULL
to	NULL
the	NULL
wild-type	NULL
element	NULL
)	NULL
occur	NULL
.	NULL

In	NULL
construct	NULL
11	NULL
,	NULL
the	NULL
DRA	NULL
Xl-element	NULL
5'-CCTAGCAA-CAGA-3	NULL
'	NULL
is	NULL
replaced	NULL
with	NULL
the	NULL
DQB	NULL
Xl-element	NULL
5	NULL
'	NULL
(	NULL
-CCCA-GAGACAGA-3	NULL
'	NULL
.	NULL

In	NULL
construct	NULL
12	NULL
,	NULL
the	NULL
DRA	NULL
X2-element	NULL
5'-TGCGTCATCTC-3	NULL
'	NULL
is	NULL
replaced	NULL
with	NULL
the	NULL
DQB	NULL
X2-element	NULL
TGAGGTCCTTC-3	NULL
'	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
replacement	NULL
constructs	NULL
were	NULL
then	NULL
transfected	NULL
transiently	NULL
into	NULL
Clone-13	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
CAT	NULL
activities	NULL
were	NULL
quantitated	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Construct	NULL
10	NULL
,	NULL
containing	NULL
a	NULL
complete	NULL
replacement	NULL
of	NULL
both	NULL
X1	NULL
and	NULL
X2-elements	NULL
of	NULL
DRA	NULL
with	NULL
the	NULL
analogous	NULL
DQB	NULL
elements	NULL
had	NULL
a	NULL
transcriptional	NULL
activity	NULL
approximately	NULL
85	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
DQB	NULL
reporter	NULL
construct	NULL
.	NULL

Construct	NULL
11	NULL
,	NULL
containing	NULL
a	NULL
DQB	NULL
substitution	NULL
only	NULL
at	NULL
the	NULL
Xl-ele-ment	NULL
,	NULL
had	NULL
a	NULL
variable	NULL
transcriptional	NULL
activity	NULL
(	NULL
with	NULL
a	NULL
mean	NULL
of	NULL
7	NULL
%	NULL
of	NULL
DQB	NULL
and	NULL
a	NULL
maximum	NULL
activity	NULL
of	NULL
17	NULL
%	NULL
of	NULL
DQB	NULL
;	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

s	NULL
x1	NULL
x2	NULL
v	NULL
cat	NULL
EHJ	NULL
maom	NULL
HLA-DQB	NULL
B	NULL
120	NULL
>	NULL
100	NULL
Pr	NULL
G	NULL
M	NULL
80	NULL
I2	NULL
60	NULL
O	NULL
$	NULL
40	NULL
t	NULL
o	NULL
0	NULL
1	NULL
2	NULL
10	NULL
11	NULL
12	NULL
Construct	NULL
2	NULL
.	NULL

#	NULL
s	NULL
%	NULL
1	NULL
2	NULL
10	NULL
11	NULL
12	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Replacement	NULL
of	NULL
DRA	NULL
X2	NULL
with	NULL
DQBX2	NULL
restores	NULL
expression	NULL
to	NULL
the	NULL
DRA	NULL
reporter	NULL
plasmid	NULL
.	NULL

A	NULL
,	NULL
scheme	NULL
for	NULL
construction	NULL
of	NULL
substitution	NULL
plasmids	NULL
.	NULL

The	NULL
exact	NULL
nucleotide	NULL
sequences	NULL
that	NULL
are	NULL
replaced	NULL
are	NULL
indicated	NULL
under	NULL
``	NULL
Results	NULL
.	NULL
``	NULL

The	NULL
numbers	NULL
at	NULL
the	NULL
left	NULL
of	NULL
the	NULL
panel	NULL
refer	NULL
to	NULL
the	NULL
construct	NULL
number	NULL
used	NULL
in	NULL
the	NULL
text	NULL
.	NULL

These	NULL
replacement	NULL
plasmids	NULL
were	NULL
generated	NULL
by	NULL
overlap	NULL
PCR	NULL
.	NULL

B	NULL
,	NULL
results	NULL
of	NULL
transient	NULL
transfections	NULL
of	NULL
the	NULL
constructs	NULL
in	NULL
A	NULL
into	NULL
Clone-13	NULL
cells	NULL
.	NULL

Three	NULL
independent	NULL
plasmid	NULL
preparations	NULL
and	NULL
an	NULL
»	NULL
=	NULL
5	NULL
for	NULL
each	NULL
preparation	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
mean	NULL
values	NULL
and	NULL
S.E	NULL
.	NULL

are	NULL
indicated	NULL
by	NULL
error	NULL
bars	NULL
.	NULL

The	NULL
p	NULL
values	NULL
of	NULL
2	NULL
,	NULL
10	NULL
,	NULL
and	NULL
12	NULL
are	NULL
<	NULL
0.005	NULL
.	NULL

C	NULL
,	NULL
a	NULL
representative	NULL
CAT	NULL
assay	NULL
from	NULL
B.	NULL
Construct	NULL
12	NULL
,	NULL
containing	NULL
a	NULL
DQB	NULL
substitution	NULL
only	NULL
at	NULL
the	NULL
X2-element	NULL
,	NULL
had	NULL
a	NULL
mean	NULL
transcriptional	NULL
activity	NULL
of	NULL
88	NULL
%	NULL
of	NULL
DQB	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
DQB	NULL
X2-element	NULL
can	NULL
functionally	NULL
replace	NULL
the	NULL
DRA	NULL
X2-element	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
and	NULL
indicate	NULL
that	NULL
the	NULL
defective	NULL
transcription	NULL
factor	NULL
in	NULL
Clone-13	NULL
``	NULL
interacts	NULL
``	NULL
directly	NULL
with	NULL
or	NULL
requires	NULL
interaction	NULL
with	NULL
a	NULL
factor	NULL
bound	NULL
to	NULL
the	NULL
DRA	NULL
X2-element	NULL
.	NULL

Compensatory	NULL
Substitution	NULL
Promoters	NULL
Indicate	NULL
that	NULL
Replacement	NULL
of	NULL
the	NULL
DQB	NULL
X2-element	NULL
with	NULL
the	NULL
DRA	NULL
X2-element	NULL
Silences	NULL
DQB	NULL
Promoter	NULL
Activity	NULL
in	NULL
Clone-13	NULL
Cells-The	NULL
previous	NULL
experiments	NULL
indicated	NULL
that	NULL
replacement	NULL
of	NULL
the	NULL
DRA	NULL
X2-element	NULL
with	NULL
the	NULL
DQB	NULL
X2-element	NULL
restored	NULL
transcription	NULL
from	NULL
the	NULL
DRA	NULL
promoter	NULL
.	NULL

Depending	NULL
on	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
defect	NULL
in	NULL
the	NULL
Clone-13	NULL
DRA	NULL
X2-element	NULL
binding	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
presumably	NULL
replaced	NULL
by	NULL
the	NULL
DQB	NULL
X2-element	NULL
binding	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
on	NULL
construct	NULL
12	NULL
,	NULL
it	NULL
does	NULL
not	NULL
100	NULL
80	NULL
60	NULL
40	NULL
Relative	NULL
CAT	NULL
Activity	NULL
1	NULL
2	NULL
13	NULL
14	NULL
Construct	NULL
1	NULL
2	NULL
13	NULL
14	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Replacement	NULL
of	NULL
the	NULL
DQB	NULL
X2-element	NULL
with	NULL
the	NULL
DRA	NULL
X2-element	NULL
abolishes	NULL
transcription	NULL
from	NULL
the	NULL
DQB	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
diagram	NULL
of	NULL
the	NULL
substitution	NULL
reporter	NULL
plasmids	NULL
13	NULL
and	NULL
14	NULL
.	NULL

The	NULL
color	NULL
coding	NULL
is	NULL
as	NULL
designated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
exact	NULL
nucleotides	NULL
substituted	NULL
are	NULL
indicated	NULL
under	NULL
``	NULL
Results	NULL
.	NULL
``	NULL

Substitution	NULL
plasmids	NULL
were	NULL
synthesized	NULL
by	NULL
overlap	NULL
PCR	NULL
using	NULL
complementary	NULL
oligonucleotide	NULL
containing	NULL
substitution	NULL
sequences	NULL
at	NULL
their	NULL
5	NULL
termini	NULL
.	NULL

B	NULL
,	NULL
results	NULL
of	NULL
transient	NULL
transfection	NULL
of	NULL
plasmids	NULL
in	NULL
3A	NULL
into	NULL
Clone-13	NULL
cells	NULL
.	NULL

Statistical	NULL
analysis	NULL
was	NULL
by	NULL
analysis	NULL
of	NULL
variance	NULL
.	NULL

Constructs	NULL
2	NULL
and	NULL
14	NULL
had	NULL
p	NULL
values	NULL
of	NULL
<	NULL
0.005	NULL
relative	NULL
to	NULL
1	NULL
.	NULL

C	NULL
,	NULL
a	NULL
representative	NULL
CAT	NULL
assay	NULL
from	NULL
B.	NULL
necessarily	NULL
follow	NULL
that	NULL
the	NULL
compensatory	NULL
experiment	NULL
(	NULL
substi-tuting	NULL
the	NULL
DQB	NULL
X2-element	NULL
with	NULL
the	NULL
DRA	NULL
X2-element	NULL
)	NULL
will	NULL
yield	NULL
the	NULL
converse	NULL
result	NULL
.	NULL

To	NULL
gain	NULL
further	NULL
insight	NULL
into	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
defect	NULL
,	NULL
we	NULL
therefore	NULL
generated	NULL
two	NULL
additional	NULL
constructs	NULL
(	NULL
13	NULL
and	NULL
14	NULL
)	NULL
,	NULL
where	NULL
the	NULL
X2-	NULL
and	NULL
X1l-elements	NULL
within	NULL
the	NULL
DQB	NULL
promoter	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
replaced	NULL
with	NULL
their	NULL
DRA	NULL
counterparts	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

While	NULL
insertion	NULL
of	NULL
the	NULL
DRA	NULL
X1-element	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
DQB	NULL
promoter	NULL
activity	NULL
(	NULL
construct	NULL
14	NULL
)	NULL
,	NULL
insertion	NULL
of	NULL
the	NULL
DRA	NULL
X2-element	NULL
almost	NULL
completely	NULL
silenced	NULL
DQB	NULL
promoter	NULL
activity	NULL
(	NULL
construct	NULL
13	NULL
)	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
defect	NULL
in	NULL
the	NULL
DRA	NULL
X2-element	NULL
binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
in	NULL
Clone-13	NULL
also	NULL
prohibit	NULL
efficient	NULL
transcriptional	NULL
activation	NULL
from	NULL
the	NULL
DQB	NULL
promoter	NULL
.	NULL

The	NULL
Defect	NULL
in	NULL
the	NULL
X2-element	NULL
Binding	NULL
Protein	NULL
(	NULL
s	NULL
)	NULL
in	NULL
Clone-13	NULL
Does	NULL
Not	NULL
Affect	NULL
Multiprotein	NULL
Complex	NULL
(	NULL
Complex	NULL
A	NULL
)	NULL
Formation	NULL
on	NULL
the	NULL
DRA	NULL
Promoter-As	NULL
we	NULL
reported	NULL
in	NULL
the	NULL
original	NULL
communication	NULL
describing	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
we	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
detect	NULL
differences	NULL
in	NULL
nucleoprotein	NULL
complex	NULL
formation	NULL
with	NULL
DRA	NULL
S	NULL
,	NULL
X-	NULL
or	NULL
Y-box	NULL
oligonucleotides	NULL
in	NULL
extracts	NULL
from	NULL
wild-type	NULL
Jijoye	NULL
and	NULL
mutant	NULL
Clone-13	NULL
cell	NULL
lines	NULL
by	NULL
EMSA	NULL
analysis	NULL
.	NULL

Since	NULL
X2-Box	NULL
Control	NULL
of	NULL
Isotype	NULL
Specificity	NULL
of	NULL
MHC	NULL
Class	NULL
II	NULL
Genes	NULL
Bi-	NULL
(	NULL
Complex	NULL
A	NULL
)	NULL
B2	NULL
--	NULL
B3	NULL
B4	NULL
--	NULL
B5	NULL
--	NULL
B6	NULL
(	NULL
Oct-2	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
analysis	NULL
of	NULL
complex	NULL
formation	NULL
on	NULL
DRA	NULL
nucleotides	NULL
-141	NULL
to	NULL
-43	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
a	NULL
panel	NULL
of	NULL
class	NULL
II	NULL
positive	NULL
and	NULL
negative	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
Clone-13	NULL
.	NULL

Six	NULL
complexes	NULL
that	NULL
form	NULL
on	NULL
this	NULL
probe	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
of	NULL
the	NULL
gel	NULL
and	NULL
the	NULL
source	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
used	NULL
in	NULL
each	NULL
lane	NULL
is	NULL
indicated	NULL
above	NULL
the	NULL
gel	NULL
.	NULL

Lane	NULL
2	NULL
received	NULL
100	NULL
x	NULL
cold	NULL
competitor	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

Complex	NULL
B1	NULL
is	NULL
probably	NULL
the	NULL
same	NULL
as	NULL
complex	NULL
A	NULL
as	NULL
described	NULL
in	NULL
Finn	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Complex	NULL
B2	NULL
is	NULL
probably	NULL
complex	NULL
B	NULL
using	NULL
the	NULL
Finn	NULL
terminology	NULL
.	NULL

Complex	NULL
B5	NULL
is	NULL
due	NULL
to	NULL
Oct-1	NULL
,	NULL
and	NULL
complex	NULL
B6	NULL
is	NULL
due	NULL
to	NULL
Oct-2	NULL
.	NULL

The	NULL
reasoning	NULL
behind	NULL
these	NULL
designations	NULL
is	NULL
described	NULL
under	NULL
``	NULL
Results	NULL
.	NULL
``	NULL

several	NULL
laboratories	NULL
have	NULL
now	NULL
shown	NULL
that	NULL
the	NULL
promoters	NULL
of	NULL
many	NULL
class	NULL
II	NULL
negative	NULL
cell	NULL
lines	NULL
(	NULL
in	NULL
sharp	NULL
contrast	NULL
with	NULL
class	NULL
II	NULL
positive	NULL
cells	NULL
)	NULL
are	NULL
not	NULL
occupied	NULL
in	NULL
vivo	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
direct	NULL
promoter	NULL
binding	NULL
proteins	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
defect	NULL
in	NULL
Clone-13	NULL
cells	NULL
might	NULL
result	NULL
in	NULL
the	NULL
inability	NULL
to	NULL
form	NULL
multiprotein	NULL
complexes	NULL
on	NULL
extended	NULL
class	NULL
II	NULL
probes	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Finn	NULL
and	NULL
co-workers	NULL
(	NULL
27	NULL
)	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
a	NULL
low	NULL
mobility	NULL
complex	NULL
(	NULL
complex	NULL
A	NULL
)	NULL
,	NULL
which	NULL
forms	NULL
on	NULL
extended	NULL
class	NULL
II	NULL
MHC	NULL
probes	NULL
correlates	NULL
with	NULL
the	NULL
class	NULL
II	NULL
positive	NULL
phenotype	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
cytokine-induced	NULL
nonlymphoid	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
reported	NULL
to	NULL
be	NULL
missing	NULL
in	NULL
the	NULL
class	NULL
II	NULL
negative	NULL
mutant	NULL
cell	NULL
line	NULL
RJ2.2.5	NULL
and	NULL
restored	NULL
in	NULL
HLA	NULL
class	NULL
II	NULL
positive	NULL
interspecific	NULL
hybrids	NULL
with	NULL
a	NULL
murine	NULL
class	NULL
II	NULL
positive	NULL
cell	NULL
(	NULL
28	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
performed	NULL
a	NULL
similar	NULL
analysis	NULL
with	NULL
extracts	NULL
from	NULL
a	NULL
panel	NULL
of	NULL
human	NULL
class	NULL
II	NULL
positive	NULL
and	NULL
negative	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
Clone-13	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
our	NULL
EMSA	NULL
analysis	NULL
using	NULL
a	NULL
DRA	NULL
probe	NULL
containing	NULL
nucleotides	NULL
-141	NULL
to	NULL
-43	NULL
(	NULL
containing	NULL
the	NULL
S	NULL
,	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
octamer	NULL
elements	NULL
)	NULL
,	NULL
we	NULL
are	NULL
able	NULL
to	NULL
distinguish	NULL
six	NULL
complexes	NULL
in	NULL
EMSAs	NULL
using	NULL
extracts	NULL
from	NULL
the	NULL
class	NULL
II	NULL
positive	NULL
cell	NULL
line	NULL
,	NULL
Raji	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
two	NULL
highest	NULL
mobility	NULL
bands	NULL
,	NULL
B5	NULL
and	NULL
B6	NULL
result	NULL
from	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
octamer	NULL
motif	NULL
(	NULL
which	NULL
was	NULL
absent	NULL
in	NULL
the	NULL
probes	NULL
used	NULL
by	NULL
Finn	NULL
)	NULL
as	NULL
determined	NULL
by	NULL
competition	NULL
analyses	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Complex	NULL
B6	NULL
is	NULL
due	NULL
to	NULL
the	NULL
B	NULL
lymphoid	NULL
specific	NULL
factor	NULL
Oct-2	NULL
(	NULL
note	NULL
that	NULL
it	NULL
is	NULL
missing	NULL
in	NULL
HeLa	NULL
and	NULL
Jurkat	NULL
cells	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
and	NULL
complex	NULL
B5	NULL
is	NULL
due	NULL
to	NULL
Oct-1	NULL
binding	NULL
.	NULL

Complex	NULL
B4	NULL
is	NULL
present	NULL
in	NULL
all	NULL
cells	NULL
and	NULL
is	NULL
competed	NULL
by	NULL
any	NULL
single	NULL
element	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
is	NULL
,	NULL
therefore	NULL
,	NULL
probably	NULL
a	NULL
multiprotein	NULL
complex	NULL
containing	NULL
S	NULL
,	NULL
X1-	NULL
,	NULL
X2-	NULL
and	NULL
Y-box	NULL
binding	NULL
factors	NULL
.	NULL

Complex	NULL
B3	NULL
is	NULL
only	NULL
present	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
is	NULL
therefore	NULL
probably	NULL
the	NULL
multiprotein	NULL
complex	NULL
B3	NULL
containing	NULL
Oct-2	NULL
.	NULL

Finally	NULL
,	NULL
complexes	NULL
B1	NULL
and	NULL
B2	NULL
probably	NULL
correspond	NULL
to	NULL
Finn	NULL
's	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
,	NULL
respectively	NULL
.	NULL

Complex	NULL
B2	NULL
,	NULL
like	NULL
complex	NULL
B	NULL
,	NULL
is	NULL
a	NULL
low	NULL
mobility	NULL
complex	NULL
present	NULL
in	NULL
all	NULL
cells	NULL
,	NULL
and	NULL
complex	NULL
B1	NULL
,	NULL
like	NULL
complex	NULL
A	NULL
,	NULL
is	NULL
both	NULL
the	NULL
lowest	NULL
mobility	NULL
complex	NULL
and	NULL
only	NULL
formed	NULL
in	NULL
extracts	NULL
from	NULL
certain	NULL
cells	NULL
.	NULL

Complex	NULL
B1	NULL
(	NULL
probably	NULL
complex	NULL
A	NULL
)	NULL
in	NULL
our	NULL
hands	NULL
is	NULL
absent	NULL
in	NULL
6.1.6	NULL
,	NULL
BLS-1	NULL
,	NULL
TF	NULL
,	NULL
Hela	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
SJO	NULL
nuclear	NULL
extracts	NULL
(	NULL
this	NULL
group	NULL
contains	NULL
both	NULL
B	NULL
and	NULL
non-B	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
all	NULL
class	NULL
II	NULL
negative	NULL
)	NULL
,	NULL
X2-Box	NULL
Control	NULL
of	NULL
Isotype	NULL
Specificity	NULL
of	NULL
MHC	NULL
Class	NULL
II	NULL
Genes	NULL
but	NULL
is	NULL
present	NULL
in	NULL
Raji	NULL
,	NULL
RJ2.2.5	NULL
,	NULL
Clone-13	NULL
,	NULL
and	NULL
JY	NULL
cells	NULL
(	NULL
this	NULL
group	NULL
contains	NULL
both	NULL
class	NULL
II	NULL
positive	NULL
and	NULL
negative	NULL
B	NULL
cells	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
Finn	NULL
's	NULL
previous	NULL
reports	NULL
of	NULL
a	NULL
low	NULL
mobility	NULL
complex	NULL
that	NULL
forms	NULL
preferentially	NULL
in	NULL
class	NULL
II	NULL
positive	NULL
cells	NULL
(	NULL
note	NULL
its	NULL
absence	NULL
in	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7-10	NULL
:	NULL
all	NULL
class	NULL
II	NULL
negative	NULL
cells	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
B1	NULL
in	NULL
extracts	NULL
from	NULL
RJ2.2.5	NULL
is	NULL
at	NULL
variance	NULL
with	NULL
the	NULL
previous	NULL
findings	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
B1	NULL
in	NULL
extracts	NULL
from	NULL
Clone-13	NULL
cells	NULL
(	NULL
HLA-DR	NULL
and	NULL
-DP	NULL
negative	NULL
)	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
correlation	NULL
between	NULL
complex	NULL
B1	NULL
formation	NULL
and	NULL
class	NULL
II	NULL
positivity	NULL
is	NULL
not	NULL
one-to-one	NULL
.	NULL

These	NULL
data	NULL
do	NULL
show	NULL
that	NULL
multiprotein	NULL
complexes	NULL
can	NULL
form	NULL
on	NULL
an	NULL
extended	NULL
DRA	NULL
probe	NULL
in	NULL
EMSAs	NULL
in	NULL
both	NULL
the	NULL
RJ2.2.5	NULL
and	NULL
Clone-13	NULL
mutant	NULL
cell	NULL
lines	NULL
.	NULL

This	NULL
similar	NULL
phenotype	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
studies	NULL
of	NULL
Benichou	NULL
and	NULL
Strominger	NULL
(	NULL
18	NULL
)	NULL
that	NULL
reported	NULL
that	NULL
these	NULL
two	NULL
cell	NULL
lines	NULL
fall	NULL
into	NULL
complementation	NULL
group	NULL
II	NULL
.	NULL

All	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
that	NULL
did	NULL
not	NULL
form	NULL
complex	NULL
B1	NULL
in	NULL
this	NULL
study	NULL
fall	NULL
outside	NULL
complementation	NULL
group	NULL
II	NULL
:	NULL
BLS-1	NULL
(	NULL
group	NULL
1	NULL
)	NULL
,	NULL
6.1.6	NULL
(	NULL
group	NULL
IIID	NULL
)	NULL
,	NULL
SJO	NULL
,	NULL
and	NULL
TF	NULL
(	NULL
group	NULL
IV	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
of	NULL
the	NULL
MHC	NULL
,	NULL
like	NULL
all	NULL
other	NULL
RNA	NULL
polymerase	NULL
II	NULL
eukaryotic	NULL
genes	NULL
,	NULL
requires	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
multiprotein	NULL
complex	NULL
on	NULL
the	NULL
proximal	NULL
promoter	NULL
,	NULL
and	NULL
appropriate	NULL
interactions	NULL
between	NULL
the	NULL
upstream	NULL
activators	NULL
and	NULL
the	NULL
basal	NULL
transcriptional	NULL
machinery	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
relatively	NULL
conserved	NULL
elements	NULL
,	NULL
designated	NULL
S	NULL
,	NULL
X	NULL
,	NULL
and	NULL
Y	NULL
are	NULL
found	NULL
in	NULL
all	NULL
class	NULL
II	NULL
promoters	NULL
sequenced	NULL
to	NULL
date	NULL
,	NULL
and	NULL
a	NULL
multiplicity	NULL
of	NULL
factors	NULL
have	NULL
been	NULL
purified	NULL
and/or	NULL
molecularly	NULL
cloned	NULL
that	NULL
exhibit	NULL
varying	NULL
degrees	NULL
of	NULL
sequence-specificity	NULL
and/or	NULL
preference	NULL
for	NULL
these	NULL
and	NULL
other	NULL
elements	NULL
(	NULL
4-13	NULL
)	NULL
.	NULL

With	NULL
a	NULL
few	NULL
exceptions	NULL
,	NULL
most	NULL
of	NULL
the	NULL
promoter-bound	NULL
transcription	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
class	NULL
II	NULL
cis-elements	NULL
are	NULL
ubiquitously	NULL
expressed	NULL
and	NULL
either	NULL
do	NULL
not	NULL
or	NULL
only	NULL
weakly	NULL
activate	NULL
class	NULL
II	NULL
reporter	NULL
constructs	NULL
when	NULL
overexpressed	NULL
in	NULL
transient	NULL
assays	NULL
.	NULL

The	NULL
newly	NULL
identified	NULL
factor	NULL
,	NULL
CHTA	NULL
,	NULL
is	NULL
a	NULL
dramatic	NULL
exception	NULL
,	NULL
as	NULL
its	NULL
expression	NULL
pattern	NULL
correlates	NULL
with	NULL
class	NULL
II	NULL
positivity	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
all	NULL
of	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
upon	NULL
transfection	NULL
into	NULL
several	NULL
class	NULL
II	NULL
negative	NULL
cells	NULL
(	NULL
30	NULL
,	NULL
81	NULL
)	NULL
.	NULL

While	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
different	NULL
class	NULL
II	NULL
genes	NULL
within	NULL
a	NULL
species	NULL
are	NULL
regulated	NULL
by	NULL
overlapping	NULL
transcription	NULL
factors	NULL
(	NULL
with	NULL
CIITA	NULL
being	NULL
a	NULL
central	NULL
player	NULL
)	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
this	NULL
system	NULL
is	NULL
much	NULL
more	NULL
complex	NULL
than	NULL
originally	NULL
thought	NULL
.	NULL

Multiple	NULL
proteins	NULL
can	NULL
interact	NULL
with	NULL
each	NULL
cis-element	NULL
,	NULL
and	NULL
each	NULL
of	NULL
the	NULL
cloned	NULL
factors	NULL
has	NULL
turned	NULL
out	NULL
to	NULL
have	NULL
dramatically	NULL
different	NULL
affinities	NULL
for	NULL
their	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
different	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
82	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
field	NULL
is	NULL
only	NULL
begining	NULL
to	NULL
uncover	NULL
the	NULL
protein-protein	NULL
interactions	NULL
that	NULL
are	NULL
necessary	NULL
from	NULL
transcription	NULL
complex	NULL
assembly	NULL
,	NULL
and	NULL
additional	NULL
proteins	NULL
that	NULL
participate	NULL
in	NULL
this	NULL
process	NULL
are	NULL
probably	NULL
yet	NULL
to	NULL
be	NULL
discovered	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
provide	NULL
additional	NULL
evidence	NULL
of	NULL
the	NULL
complexity	NULL
of	NULL
this	NULL
problem	NULL
.	NULL

It	NULL
has	NULL
become	NULL
clear	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
different	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
human	NULL
cells	NULL
is	NULL
not	NULL
always	NULL
coor-dinate	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
used	NULL
the	NULL
HLA-DQ	NULL
positive	NULL
,	NULL
HLA-DR	NULL
,	NULL
and	NULL
-DP	NULL
negative	NULL
cell	NULL
line	NULL
Clone-13	NULL
,	NULL
to	NULL
investigate	NULL
a	NULL
molecular	NULL
basis	NULL
for	NULL
this	NULL
divergence	NULL
in	NULL
regulatory	NULL
mechanisms	NULL
.	NULL

This	NULL
particular	NULL
model	NULL
is	NULL
attractive	NULL
since	NULL
the	NULL
lack	NULL
of	NULL
DRA	NULL
gene	NULL
expression	NULL
in	NULL
this	NULL
cell	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
influence	NULL
of	NULL
chromatin	NULL
structure	NULL
or	NULL
distant	NULL
elements	NULL
but	NULL
has	NULL
been	NULL
mapped	NULL
to	NULL
the	NULL
immediate	NULL
proximal	NULL
promoter	NULL
in	NULL
transient	NULL
assays	NULL
.	NULL

Using	NULL
a	NULL
series	NULL
of	NULL
hybrid	NULL
and	NULL
substitution	NULL
constructs	NULL
,	NULL
we	NULL
show	NULL
here	NULL
that	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
the	NULL
DRA	NULL
and	NULL
DQB	NULL
genes	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
divergent	NULL
X2-box	NULL
element	NULL
(	NULL
Figs	NULL
.	NULL

1-3	NULL
)	NULL
.	NULL

The	NULL
DQB	NULL
X2-element	NULL
can	NULL
restore	NULL
transcriptional	NULL
activity	NULL
to	NULL
the	NULL
DRA	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
and	NULL
the	NULL
DRA	NULL
X2-element	NULL
can	NULL
abolish	NULL
transcription	NULL
from	NULL
the	NULL
DQB	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
X2	NULL
binding	NULL
factors	NULL
utilized	NULL
by	NULL
the	NULL
two	NULL
genes	NULL
are	NULL
distinct	NULL
.	NULL

These	NULL
results	NULL
further	NULL
6401	NULL
indicate	NULL
that	NULL
the	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
DQB	NULL
X2-element	NULL
can	NULL
,	NULL
however	NULL
,	NULL
functionally	NULL
replace	NULL
the	NULL
factors	NULL
that	NULL
normally	NULL
bind	NULL
to	NULL
the	NULL
DRA	NULL
X2-element	NULL
.	NULL

This	NULL
in	NULL
turn	NULL
implies	NULL
that	NULL
the	NULL
DQB	NULL
X2	NULL
factors	NULL
can	NULL
participate	NULL
in	NULL
any	NULL
of	NULL
the	NULL
required	NULL
protein-protein	NULL
interactions	NULL
in	NULL
which	NULL
the	NULL
DRA	NULL
X2	NULL
factors	NULL
normally	NULL
participate	NULL
.	NULL

The	NULL
data	NULL
also	NULL
indicate	NULL
that	NULL
the	NULL
defect	NULL
in	NULL
the	NULL
DRA	NULL
X2-associated	NULL
factor	NULL
in	NULL
Clone-13	NULL
is	NULL
drastic	NULL
enough	NULL
to	NULL
prohibit	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
active	NULL
transcription	NULL
complex	NULL
with	NULL
the	NULL
other	NULL
constituents	NULL
of	NULL
the	NULL
normal	NULL
DRA	NULL
or	NULL
DQB	NULL
transcription	NULL
complexes	NULL
.	NULL

The	NULL
concept	NULL
that	NULL
the	NULL
DRA	NULL
and	NULL
DQB	NULL
genes	NULL
bind	NULL
different	NULL
factors	NULL
to	NULL
their	NULL
X2-elements	NULL
is	NULL
consistent	NULL
with	NULL
1	NULL
)	NULL
sequence	NULL
divergence	NULL
at	NULL
this	NULL
site	NULL
between	NULL
the	NULL
two	NULL
promoters	NULL
(	NULL
4-6	NULL
)	NULL
,	NULL
2	NULL
)	NULL
multiple	NULL
previous	NULL
EMSA	NULL
experiments	NULL
involving	NULL
cross-competi-tions	NULL
and	NULL
using	NULL
recombinant	NULL
X2-binding	NULL
proteins	NULL
(	NULL
6	NULL
,	NULL
34	NULL
)	NULL
,	NULL
3	NULL
)	NULL
the	NULL
results	NULL
of	NULL
antisense	NULL
inhibition	NULL
experiments	NULL
where	NULL
antisense	NULL
hXBP-1	NULL
and	NULL
c-fos	NULL
RNAs	NULL
specifically	NULL
affected	NULL
DR	NULL
and	NULL
DP	NULL
antigen	NULL
expression	NULL
,	NULL
and	NULL
DRA	NULL
but	NULL
not	NULL
DQB	NULL
promoter	NULL
activity	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
and	NULL
4	NULL
)	NULL
our	NULL
studies	NULL
on	NULL
the	NULL
steroid	NULL
sensitivities	NULL
of	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
that	NULL
indicate	NULL
that	NULL
DR	NULL
and	NULL
DP	NULL
(	NULL
but	NULL
not	NULL
DQ	NULL
)	NULL
antigen	NULL
expression	NULL
,	NULL
and	NULL
DRA	NULL
but	NULL
not	NULL
DQB	NULL
promoter	NULL
activity	NULL
are	NULL
inhibited	NULL
by	NULL
steroids	NULL
.	NULL
``	NULL

The	NULL
concept	NULL
that	NULL
the	NULL
distinct	NULL
X2-binding	NULL
proteins	NULL
can	NULL
substitute	NULL
for	NULL
each	NULL
other	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
recent	NULL
independent	NULL
studies	NULL
of	NULL
Voliva	NULL
and	NULL
Reith	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Voliva	NULL
showed	NULL
that	NULL
substitution	NULL
promoters	NULL
(	NULL
including	NULL
core	NULL
X-box	NULL
replacements	NULL
)	NULL
can	NULL
function	NULL
despite	NULL
clear	NULL
evidence	NULL
that	NULL
both	NULL
common	NULL
and	NULL
unique	NULL
proteins	NULL
interact	NULL
with	NULL
class	NULL
II	NULL
MHC	NULL
cis-elements	NULL
.	NULL

Reith	NULL
and	NULL
co-workers	NULL
showed	NULL
that	NULL
one	NULL
member	NULL
of	NULL
the	NULL
RFX	NULL
family	NULL
of	NULL
proteins	NULL
binds	NULL
cooperatively	NULL
with	NULL
one	NULL
of	NULL
several	NULL
potential	NULL
Y-box	NULL
binding	NULL
proteins	NULL
,	NULL
NF-Y	NULL
.	NULL

This	NULL
interaction	NULL
occurred	NULL
in	NULL
vitro	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
X2-element	NULL
,	NULL
indicating	NULL
that	NULL
RFX/NF-Y	NULL
interaction	NULL
does	NULL
not	NULL
require	NULL
an	NULL
X2BP	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
X2-element	NULL
decreases	NULL
class	NULL
II	NULL
promoter	NULL
activity	NULL
might	NULL
suggest	NULL
that	NULL
each	NULL
distinct	NULL
X2BP	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
divergent	NULL
X2-elements	NULL
provides	NULL
a	NULL
common	NULL
generic	NULL
function	NULL
(	NULL
such	NULL
as	NULL
contributing	NULL
to	NULL
a	NULL
multiprotein	NULL
activation	NULL
surface	NULL
or	NULL
assisting	NULL
in	NULL
the	NULL
tethering	NULL
of	NULL
CIITA	NULL
to	NULL
the	NULL
promoter	NULL
)	NULL
.	NULL

The	NULL
resolution	NULL
of	NULL
these	NULL
issues	NULL
requires	NULL
the	NULL
isolation	NULL
of	NULL
each	NULL
component	NULL
of	NULL
the	NULL
DRA	NULL
and	NULL
DQB	NULL
transcription	NULL
complexes	NULL
,	NULL
and	NULL
a	NULL
systematic	NULL
analysis	NULL
of	NULL
protein/protein	NULL
interactions	NULL
between	NULL
these	NULL
factors	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Kostya	NULL
Ebralidse	NULL
and	NULL
Dimitris	NULL
Thanos	NULL
for	NULL
stimulating	NULL
discussions	NULL
.	NULL

REFERENCES	NULL
.	NULL

Germain	NULL
,	NULL
R.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
287-299	NULL
Kappes	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Strominger	NULL
,	NULL
J.1	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

57	NULL
,	NULL
991-1028	NULL
.	NULL

Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
681-715	NULL
-	NULL
.	NULL

Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
Kara	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
13-49	NULL
Pujol-Borrell	NULL
,	NULL
R.	NULL
,	NULL
Todd	NULL
,	NULL
I.	NULL
,	NULL
Doshi	NULL
,	NULL
M.	NULL
,	NULL
Bottazzo	NULL
,	NULL
G.	NULL
F.	NULL
,	NULL
Sutton	NULL
,	NULL
R.	NULL
,	NULL
Adolf	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Feldman	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
326	NULL
,	NULL
304-306	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
Satola	NULL
,	NULL
S.	NULL
,	NULL
Sanchez	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Amaldi	NULL
,	NULL
I.	NULL
,	NULL
Lisowska-Grospiere	NULL
,	NULL
B.	NULL
,	NULL
Griscelli	NULL
,	NULL
C.	NULL
,	NULL
Hadam	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
897-906	NULL
.	NULL

Ting	NULL
,	NULL
J.	NULL
P.-Y	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Immunol	NULL
.	NULL

Res	NULL
.	NULL

12	NULL
,	NULL
65-77	NULL
.	NULL

Ono	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Bazil	NULL
,	NULL
V.	NULL
,	NULL
Levi	NULL
,	NULL
B.-Z	NULL
.	NULL

,	NULL
Ozato	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
4304-4308	NULL
9	NULL
.	NULL

Ono	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Davidon	NULL
,	NULL
R.	NULL
,	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
,	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
4309-4312	NULL
10	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
Barras	NULL
,	NULL
E.	NULL
,	NULL
Satola	NULL
,	NULL
S.	NULL
,	NULL
Kobr	NULL
,	NULL
M.	NULL
,	NULL
Reinhart	NULL
,	NULL
D.	NULL
,	NULL
Sanchez	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
4200-4204	NULL
11	NULL
.	NULL

Song	NULL
,	NULL
Z.	NULL
,	NULL
Krishna	NULL
,	NULL
S.	NULL
,	NULL
Thanos	NULL
,	NULL
D.	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Ono	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
,	NULL
1763-1774	NULL
12.	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Li	NULL
,	NULL
X.	NULL
Y.	NULL
,	NULL
Black	NULL
,	NULL
D.	NULL
,	NULL
Matthes	NULL
,	NULL
H.	NULL
,	NULL
Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
3119-3127	NULL
13	NULL
.	NULL

Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Ruppert	NULL
,	NULL
S.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
336	NULL
,	NULL
544-551	NULL
14	NULL
.	NULL

Symington	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Levine	NULL
,	NULL
F.	NULL
,	NULL
Braun	NULL
,	NULL
M.	NULL
,	NULL
Brown	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Erlich	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
and	NULL
Torok-Storb	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

185	NULL
,	NULL
1026-1032	NULL
15	NULL
.	NULL

Lucey	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Nicholson-Weller	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Weller	NULL
,	NULL
P.	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
1848-1351	NULL
16	NULL
.	NULL

Ono	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Bazil	NULL
,	NULL
V.	NULL
,	NULL
Sugawara	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

go	NULL
~3	NULL
°	NULL
L.	NULL
M.	NULL
Schweibert	NULL
,	NULL
S.	NULL
Radka	NULL
,	NULL
R.	NULL
P.	NULL
Schleimer	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Ono	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

6402	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

173	NULL
,	NULL
629-637	NULL
Henle	NULL
,	NULL
W.	NULL
,	NULL
Diehl	NULL
,	NULL
V.	NULL
,	NULL
Kohn	NULL
,	NULL
G.	NULL
,	NULL
zurHausen	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Henle	NULL
,	NULL
G.	NULL
(	NULL
1967	NULL
)	NULL
Science	NULL
157	NULL
,	NULL
1064-1065	NULL
Hinuma	NULL
,	NULL
Y.	NULL
,	NULL
Konn	NULL
,	NULL
M.	NULL
,	NULL
Yamaguchi	NULL
,	NULL
J.	NULL
,	NULL
Wudarski	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Blakeslee	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Grace	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Jr.	NULL
(	NULL
1967	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

1	NULL
,	NULL
1045-1051	NULL
Heston	NULL
,	NULL
L.	NULL
,	NULL
Rabson	NULL
,	NULL
M.	NULL
,	NULL
Brown	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Miller	NULL
,	NULL
G.	NULL
(	NULL
1982	NULL
)	NULL
Nature	NULL
295	NULL
,	NULL
160-163	NULL
Gladstone	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Pious	NULL
,	NULL
D.	NULL
(	NULL
1978	NULL
)	NULL
Nature	NULL
271	NULL
,	NULL
459-461	NULL
Benichou	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
4285-4288	NULL
Das	NULL
,	NULL
H.	NULL
,	NULL
Lawrance	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
and	NULL
Weissman	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

80	NULL
,	NULL
3543-3547	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Vilen	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Penta	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Ting	NULL
,	NULL
J.	NULL
P.-Y	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
29728-23734	NULL
Kara	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
252	NULL
,	NULL
709-712	NULL
Wright	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
Ting	NULL
,	NULL
J.	NULL
P.-Y	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Not	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
7601-7605	NULL
Finn	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Kara	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Tran	NULL
Van	NULL
,	NULL
T.	NULL
,	NULL
Douhan	NULL
,	NULL
J.	NULL
,	NULL
Boothby	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
28	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

X2-Box	NULL
Control	NULL
of	NULL
Isotype	NULL
Specificity	NULL
of	NULL
MHC	NULL
Class	NULL
II	NULL
Genes	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
1543-1549	NULL
Finn	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Van	NULL
,	NULL
T.	NULL
T.	NULL
,	NULL
Accolia	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
2159-2164	NULL
.	NULL

Tjian	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
5-8	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
Otten	NULL
,	NULL
L.	NULL
,	NULL
Zufferey	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
75	NULL
,	NULL
185-146	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
Siegrist	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Mottet	NULL
,	NULL
A.	NULL
,	NULL
Lisowska-Grospierre	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
106-109	NULL
.	NULL

Kobr	NULL
,	NULL
M.	NULL
,	NULL
Reith	NULL
,	NULL
W.	NULL
,	NULL
Herrero-Sanchez	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
965-971	NULL
Wright	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Vilen	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Itoh-Lindstrom	NULL
,	NULL
Moore	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Li	NULL
,	NULL
G.	NULL
,	NULL
Criscitiello	NULL
,	NULL
M.	NULL
,	NULL
Cogswell	NULL
,	NULL
P.	NULL
,	NULL
Clarke	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Ting	NULL
,	NULL
J.	NULL
P.-Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
4042-4053	NULL
Boothby	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immumol	NULL
.	NULL

142	NULL
,	NULL
1005-1014	NULL
Reith	NULL
,	NULL
W.	NULL
,	NULL
Siegrist	NULL
,	NULL
C.-A	NULL
.	NULL

,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Barras	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
554-558	NULL
Voliva	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Tsang	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Peterlin	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
3408-3412	NULL

